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1.0. Introduction 
 
Gamma herpesviruses are lymphotropic viruses which establish lifelong infections in 
their hosts and are associated with cellular transformation and the development of 
malignancies, particularly in immunosuppressed individuals such as AIDS patients 
(Rickinson and Kieff 2001; Kieff and Rickinson 2001; Chang et al. 1994; Moore and 
Chang 1995). Until recently, mechanistic studies of the role of immunity in gamma 
herpesvirus infection have been hampered by the species specificity of human 
herpesviruses, Epstein-Barr virus (EBV) and human herpesvirus-8 (HHV-8) and the 
difficulties and expense inherent in analyzing pathogenesis, tumor induction, and 
mechanisms of immunity in primate models. Infection of laboratory mice with murine 
gamma herpesvirus-68 (MHV-68) provides a small animal model for addressing 
fundamental issues in gamma herpesvirus pathogenesis and immunity (Nash et al. 2001; 
Simas and Efstathiou 1998; Stevenson 2004; Stevenson et al. 2002 b; Speck and Virgin 
1999; Virgin et al. 1997; Virgin and Speck 1999). MHV-68 was originally isolated from 
the bank vole (Clethrionomys glareolus) in Slovakia and is a natural pathogen for mice 
(Blaskovic et al. 1980). The overall similarities of MHV-68 to other gamma 
herpesviruses in terms of genomic organization, pathological symptoms and the 
establishment of both lytic and latent phase of infection make it a valuable model. 
 
 
1.1. Herpesviruses  
 
The family of herpesviruses is classified on the basis of the architecture of the virion. A 
typical herpesvirion consists of a core containing a linear double stranded DNA, an 
icosadeltahedral capsid approximately 100 to 110 nm in diameter containing 162 
capsomeres with a hole running down the axis, an amorphous-appearing tegument 
which surrounds the capsid, and an envelope containing viral glycoprotein spikes on the 
surface (as reviewed by Roizman and Pellet 2001). All herpesviruses examined to date 
are able to remain latent in their natural hosts. In cells harboring latent virus, viral 
genomes persist as closed circular molecules, and only a small subset of viral genes is 
expressed. Latent genomes retain the capacity to replicate and cause disease upon 
reactivation. On the basis of their biological properties and DNA sequences, the 
members of the Herpesviridae family are divided into 3 subfamilies: 
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Alphaherpesvirinae, Betaherpesvirinae and Gammaherpesvirinae (Roizman and Pellet 
2001). 
 
 
1.1.1. The Alphaherpesvirinae subfamily  
 
Alphaherpesvirinae have a broad host range and a relatively short reproductive cycle. 
They rapidly spread in culture and efficiently destroy infected cells. They have the 
capacity to establish latent infections primarily but not exclusively in sensory ganglia (as 
reviewed by Roizman and Pellet 2001). This subfamily contains the genera Simplexvirus 
(HSV-1, HSV-2), Varicellovirus (VZV), Marek’s disease like virus and Infectious 
laryngotracheitis-like virus. 
 
 
1.1.2. The Betaherpesvirinae subfamily  
 
The members of the Betaherpesvirinae subfamily are characterized by a restricted host 
range and a long reproductive cycle. Infected cells frequently become enlarged 
(cytomegalia) and carrier cultures are readily established. Latent viruses can be found in 
secretory glands, lymphoreticular cells, kidneys, and some other tissues (as reviewed by 
Roizman and Pellet 2001). The members of this subfamily are Human Cytomegalovirus 
(HCMV), Muromegalovirus (murine cytomegalovirus), and Roseolovirus (HHV-7). 
 
 
1.1.3. The Gammaherpesvirinae subfamily 
 
The experimental host range of the members of the subfamily Gammaherpesvirinae is 
limited to the family or order to which the natural host belongs (as reviewed by 
Roizman and Pellet 2001). Most of these viruses are characterized by the establishment 
of lifelong infection in their host, association with cellular transformation and the 
development of malignancies (Simas and Efstathiou 1998). In vitro, all members 
replicate in lymphoblastoid cells, some also cause lytic infections in some types of 
epitheloid and fibroblastic cells. Viruses in this group are usually specific for either T or 
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B lymphocytes (as reviewed by Roizman and Pellet 2001). Members of the 
Gammaherpesvirinae subfamily are divided into two groups, gamma-1 herpes viruses,  
which are B-lymphotropic viruses, e.g., Epstein-Barr virus and genetically related 
viruses of old world primates, and the gamma-2 herpes viruses (rhadinoviruses), e.g., 
herpes virus saimiri (HVS) of new world monkeys, HHV-8 and MHV-68 (Simas and 
Efstathiou 1998). The sub-grouping of these viruses is based on the genomic 
organization and the gene content of representative sequenced members of gamma 
herpesviruses.   
 
 
1.2. Human herpesvirus-8 (HHV-8) 
 
Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) or HHV-8, which was discovered in 
1994 (Chang et al. 1994), belongs to the subfamily of gamma-2 herpesviruses. HHV-8’s 
full length genome is 165-170 kbp (as reviewed by Moore and Chang 2001) and 
contains a 140-145 kbp single continuous region flanked by repeats of 803 bp in length 
(Lagunoff and Ganem 1997). HHV-8 codes for several potential oncogenic proteins 
(Neipel and Fleckenstein 1999); however, the pattern of HHV-8 gene expression in de 
novo infection and during initial lymphomagenesis is not known. 
HHV-8 is associated with Kaposi’s Sarcoma (KS), Multicentric Castleman’s Disease 
(MCD) and Primary Effusion Lymphoma (PEL). KS is a tumor of endothelial cell 
origin, whereas PEL is a B-cell lymphoma, and MCD is B-cell lymphoproliferative 
disorder. These tumors are most frequently found in immunosuppressed patients (as 
reviewed by Moore and Chang 2001; Dourmishev et al. 2003). Compared to most of the 
herpesviruses, HHV-8 is not ubiquitous, and only small minorities of people in most 
developed countries are HHV-8 positive (as reviewed by Moore and Change 2001). The 
primary reservoir for persistent asymptomatic HHV-8 infection appears to be CD19+ B 
cells (Ambroziak et al. 1995). However, the natural infection of endothelial cells, 
CD68+ monocyte-macrophage cells, prostate epithelia, and dorsal root sensory ganglion 
cells has been reported (as reviewed by Moore and Chang 2001). HHV-8 establishes 
latency in B cells, endothelial cells, monocytes/macrophages, and dendritic cells (as 
reviewed by Moore and Chang 2001).  
Within KS tumors virtually all spindle cells have detectable viral DNA and protein, but 
most of the cells are latently infected and do not generate lytic virus (Boshoff et al. 
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1995; Dupin et al. 1999; Orenstein et al. 1997). However, HHV-8 can be reactivated in 
vitro from PEL B-cell lymphomas and from peripheral blood cells of PEL patients by 
treating the latently infected cells with chemicals like phorbol myristate acetate (PMA) 
and butyrate (Wang et al. 1998; Yu et al. 1999). Although HHV-8 encodes a large 
number of transforming genes, HHV-8-associated malignancies are often seen in the 
context of immune suppression. This suggests that the normal host immune surveillance 
mechanisms in healthy individuals are generally able to keep HHV-8 in check. 
 
 
1.3. Epstein–Barr virus 
 
EBV or human herpesvirus 4 (HHV-4) was discovered in 1965 (Epstein et al. 1965) and 
belongs to the genus Lymphocryptovirus within the subfamily of gamma herpesviruses. 
More than 90% of the world's population is latently infected with EBV. 
The EBV genome is composed of a linear, double-stranded DNA of 184 kbp and 
approximately 60% (G+C) content (as reviewed by Kieff and Rickinson 2001). The in 
vitro host range for efficient EBV infection is restricted to primary human B 
lymphocytes. However, B lymphocytes derived from peripheral blood, tonsils, or fetal 
cord blood, T cells, natural killer cells, squamous epithelial cells, glandular epithelium, 
smooth muscle cells and follicular epithelial cells can be infected although with a lower 
efficiency compared to primary B cells (as reviewed by Kieff and Rickinson 2001; 
Volpi 2004). Upon EBV infection, primary B cells become activated and undergo 
morphological changes. These morphological changes are also associated with the entry 
of cells into the cell cycle, continuous proliferation and often establishment of latently 
infected lymphoblastoid cell lines (LCLs) (as reviewed by Bornkamm and 
Hammerschmidt 2001). EBV-immortalized cells or LCLs express a limited number of 
genes, which include six nuclear antigens EBNA-1, 2, 3A, 3B, 3C and EBNA-LP, two 
latent membrane proteins 1 and 2, and two small nuclear non-polyadenylated RNAs (as 
reviewed by Bornkamm and Hammerschmidt  2001; Kieff and Rickinson 2001).  
EBV is primarily transmitted by saliva. Primary infection of EBV is marked by active 
viral replication in the epithelial cells of the oropharynx and subsequent infection of 
recirculating B lymphocytes (as reviewed by Rickinson and Kieff 2001). Most of the 
time, primary infections in children are asymptomatic. However, infection during 
adolescence or young adulthood leads to infectious mononucleosis (IM) in 35-50% of 
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cases (Evans et al. 1968; Henke et al. 1973; as reviewed by Rickinson and Kieff 2001). 
The symptoms of IM are fever, sore throat, swollen lymph nodes, splenomegaly and 
malaise (Bailey 1994).  
EBV is associated with human tumours like Burkitt's lymphoma, nasopharyngeal 
carcinoma, lymphoproliferative disease in transplant patients and X-linked 
lymphoproliferative disorder. EBV also has been linked to other neoplasias including 
Hodgkin's disease, peripheral T cell tumours and gastric cancer (as reviewed by 
Damania 2004; Kuppers 2003; Rickinson and Kieff 2001; Young and Rickinson 2004; 
Volpi 2004).  
Considerable progress has been made in understanding EBV infection and the immune 
responses against it. However, the role of viral genes and the immune response to the 
pathogenesis of EBV infection is limited, due to the species specificity of the virus and 
the lack of a proper experimental model. Although transgenic mice models expressing 
genes of EBV (Baichwal and Sugden 1988; Caldwell et al. 1998; Fu et al. 2004; 
Kulwichit et al. 1998; Wang et al. 1985), and NOD/SCID mice engrafted with human 
CD34+ cells which are reconstituted mainly with human B lymphocytes (Islas-Ohlmayer 
et al. 2004) have been used to study EBV infection and pathogenesis, these models do 
not reflect a natural infection, pathogenesis and immunity in the natural host. Therefore, 
a small animal model that reproduces the biology of EBV infection would be beneficial 
for hypothesis testing, in particular for the analysis of individual viral gene functions in 
vivo (Rickinson and Kieff 2001). 
 
 
1.4. Murine gamma herpesvirus-68 (MHV-68) 
 
MHV-68 was originally isolated from the bank vole (Clethrionomys glareolus) in 
Slovakia (Blaskovic et al. 1980) during a study on the ecology of arboviruses. However, 
Blasdell et al. found that wood mice (Apodemus sylvaticus) are the natural host for 
MHV-68 and not the two species of voles (Clethrionomys glareolus and Microtus 
agrestis) (Blasdell et al. 2003). Other related murine gamma herpesviruses are MHV-60 
and MHV-72 which were isolated from bank voles, and MHV-76 and MHV-78 which 
were isolated from wood mice. MHV-68 shares similar serological and biological 
properties with other virus isolates recovered from wood mice (Apodemus flavicollis) in 
Northern Europe. Intranasal infection of mice with MHV-68 leads to an acute, 
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productive infection in alveolar epithelial and mononuclear cells in the lung and to a 
persistent infection in B-lymphocytes, macrophages, dendritic cells and epithelial cells 
of the lung. The key features of the MHV-68 that are shared by other gamma 
herpesviruses and by which it can be defined as a model for gamma herpesvirus 
pathogenesis and immunity are: 
 
 
1.4.1. Features of the MHV-68 genome 
 
The MHV-68 genome consists of a unique DNA sequence, approximately 118 kbp in 
length, with a G+C content of 46%. It is flanked by multiple copies of terminal repeats 
of 1.23 kbp in length, having a G+C content of 77.6% (Efstathiou  et al.1990 a & b).  
The G+C contents of the unique region as well as of the terminal repeats of MHV-68 are 
comparable with that of HHV-8 (Fig. 1.1).  
 
 
Humans
Humans
Natural host
Squirrel monkeys
Bank vole
Genomic structure
TR
172 kbp, 60 % G+C
113 kbp, 35 % G+C
118 kbp, 46 % G+C
141 kbp, 53.5 % G+C
TR
TR TR
TR TR
(d) HHV-8
(c) MHV-68
(b) HVS
(a) EBV
Gamma 
herpes virus
TR TR
 
 
Fig. 1.1. The genomic structure of representative members of the gamma herpesvirus family: (a) 
Epstein-Barr virus (EBV); (b) herpesvirus saimiri (HVS); (c) murine gamma herpesvirus-68 (MHV-68); 
(d) human herpesvirus-8 (HHV-8). Characteristically, the gamma herpesviruses consist of a central unique 
segment of low G+C DNA (L-DNA) ranging from 110-175 kbp, flanked by repetitive high G+C DNA 
(H-DNA). 
 
(modified from Simas and Efstathiou 1998) 
 
 
The MHV-68 genome has been sequenced by two laboratories (Nash et al. 2001; Virgin 
et al. 1997). Virgin et al. estimated that MHV-68 codes for at least 80 ORFs, out of 
which 63 ORFs are collinear and homologous to other gamma herpesviruses. MHV-68 
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shares blocks of conserved genes with other gamma herpesviruses and these blocks of 
conserved genes are interspersed by open reading frames (ORFs) that are in general 
unique to each individual family member (Fig. 1.2). These genes are thought to be 
responsible for modulating the immune response, cell transformation and latency (Simas 
and Efstathiou 1998). It appears that each virus has developed unique mechanisms to 
evade the immune response and establish latency and malignancies (Nash et al. 2001; 
Simas and Efstathiou; Speck and Virgin 1999; Virgin et al. 1997; Virgin and Speck 
1999).  
 
 
(a) HVS
(b) MHV-68
(c) HHV-8
(d) EBV
CC
PH
CC
PH
CC
PH
bc
l-2
bc
l-2
bc
l-2
bc
l-2
Cy
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n D
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cli
n D
vIL
-8-
R
vIL
-8-
R
vIL
-8-
R
K3
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Fig. 1.2. A comparison of the genetic organization among the fully sequenced gamma herpesviruses. 
The genomes of (a) herpes virus saimiri (HVS), (b) murine gamma herpesvirus-68 (MHV-68), (c) human 
herpesvirus-8 (HHV-8), and (d) Epstein-Barr virus (EBV) are shown. The genome of EBV has been 
inverted relative to its conventional orientation. The conserved gene blocks I (green), II (blue), III 
(yellow) and IV (red) are shown within these boxes and virus specific genes are shown in triangles. 
Abbreviations: bcl-2, B cell lymphoma gene 2; CCPH, complement control protein homologue; Cyclin D, 
Cyclin D homologue; vIL-8-R, viral IL-8 receptor.  
 
(modified from Simas and Efstathiou 1998) 
 
 
During the lytic phase of herpesvirus infection, DNA replication proteins assemble at an 
origin of lytic replication (ori Lyt) and initiate the replication process, resulting in 
“head-to-tail” concatemers (as reviewed by Kieff and Rickinson 2001; Mocarski and 
Courcelle 2001; Roizman and Knipe 2001).  The ori Lyt regions of rhesus macaque 
rhadinovirus, EBV, bovine herpesvirus-4 and HHV-8 have been identified (AuCoin et 
al. 2002; Hammerschmidt and Sugden 1988; Pari et al. 2001; Zimmermann et al. 2001). 
All these herpesviruses have two copies of ori Lyt. In case of MHV-68, one copy of ori 
Lyt has been identified at the right end of the genome (Deng et al. 2004), and a second 
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copy has been proposed to be situated at the left end of the genome (Coleman et al. 
2003). Both ori Lyt regions have A/T-rich and G/C-rich regions characteristic of 
herpesvirus lytic origins of replication. Also, the function of ori Lyt has been confirmed 
for the equivalent regions of HHV-8 and rhesus monkey rhadinovirus (RRV) (AuCoin et 
al. 2002; Pari et al. 2001). 
The MHV-68 genome, like other gamma-2 herpesviruses, has a marked suppression of 
CpG dinucleotides. This suppression of CpG dinucleotides might be due to the 
mutagenic effects of genomic methylation and viral DNA maintenance in dividing cell 
populations (Honess et al. 1989; Simas and Efstathiou 1998). All known gamma 
herpesviruses encode small non-coding RNAs. MHV-68 is no exception and encodes 
eight unique tRNA like sequences. These tRNA like sequences are expressed in both 
lytic and latent infection (Bowden et al. 1997; Virgin et al. 1997). The function of these 
uncharged viral tRNAs is unknown. However, the viral tRNA transcript expression can 
be detected up to 70 days post infection in the germinal centers of latently infected 
spleens of mice and therefore represents a marker for latent infection in the same way as 
the EBV encoded RNAs (EBERs) and HVS U-RNAs. 
 
 
1.4.2. Infection of cells in vitro  
 
In contrast to the two human gamma herpesviruses HHV-8 and EBV, in vitro MHV-68 
infects and replicates in a broad range of cell types from both humans and mice, 
including fibroblasts, epithelial cell lines and primary macrophages (Blaskovic et al. 
1980; Svobodova et al. 1982). MHV-68 infects primary B cells efficiently, leading to 
the formation of clumps of enlarged, activated cells within three to four days (Dutia et 
al. 1999 b; Stevenson and Doherty 1999). However, these cells do not become 
transformed and usually die within two weeks.  
 
 
1.4.3. In vivo infection 
 
The natural route of infection with MHV-68 is not known. Other gamma herpesviruses 
are transmitted through the respiratory tract, therefore it is likely that this is also true for 
MHV-68 (Simas and Efstathiou 1998). Intranasal infection (i.n.) of MHV-68 in 4-6 
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week old mice leads to productive infection in the lungs (Cardin et al. 1996; Sunil-
Chandra et al. 1992 a) followed by virus dissemination and establishment of persistent, 
life-long latent infection in B lymphocytes (Fig. 1.3). Alternative routes of infection, 
including intravenous, intraperitoneal (i.p.), and gastric instillation have also been used 
experimentally (Sunil-Chandra 1992 a; Weck et al. 1996; Peacock and Bost 2000). In 
vivo, MHV-68 infects a broad range of cells of different tissue types including epithelial 
cells from the oral and nasal cavities, lung and gastrointestinal tracts, B cells, 
macrophages, dendritic cells in the spleen and liver cells (Flano et al. 2000; Stewart et 
al. 1998; Sunil-Chandra et al. 1992 b; Weck et al. 1999).  
 
 
Further dissemination
I.n. infection of C57BL/6 or
BALB/c mice with MHV-68
Lungs (Lytic replication)
Lymph nodes
Lytic virus
Latently infected cells
Reactivation
Latently infected cells
Reactivation
 
 
Fig. 1.3. In vivo replication. After i.n. infection, MHV-68 replicates lytically in the respiratory tract. This 
is followed by seeding to lymphoid tissue, where there is amplification of latent virus and further 
dissemination, probably via latently infected memory B cells. Latent virus persists in the lung, in 
lymphoid tissue and also in other sites. 
 
(modified from Stevenson et al. 2002 b) 
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1.4.3.1. Lytic Replication 
 
Introducing virus intranasally into 5-6 weeks old inbred mice results in an acute, 
productive infection of alveolar epithelial cells, with some mononuclear cells in the lung 
also positive for late virus gene expression (Sunil-Chandra, et al. 1992 a). The virus titer 
in the lungs reaches the peak around day 6 post infection and within two weeks post 
infection acute infection gets resolved from the lungs of mice (Fig. 1.4). Acute infection 
in the lung is resolved by CD8+ T cells with or without the help of CD4+ T cells, which 
is followed by a life-long latent infection in lymphoid tissue (Cardin et al. 1996; 
Ehtisham et al. 1993). Infectious virus can also be consistently detected during acute 
infection in the adrenal glands and heart tissues, indicating that MHV-68 has a 
hematogenous spread (Sunil-Chandra et al. 1992 a; Cardin et al. 1996). Infection of the 
lung is accompanied by bronchiolitis (interstitial pneumonia) (Sunil-Chandra et al. 1992 
a; Cardin et al. 1996).  
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Fig.1.4. Lytic replication of MHV-68 in the lungs of mice.  Following i.n. infection, the virus 
replication in the lungs of immunocompetent mice (solid line) and immunocompromised mice e.g. CD4+ 
T cell-deficient mice (I-Ab-/-) mice (dashed line) is shown.  
 
(modified from Stevenson et al. 2002 b) 
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1.4.3.2. Latency 
 
Like all herpesviruses, MHV-68 establishes latency in its host. Latency is usually 
assessed by an “infectious center assay” or the “ex vivo reactivation assay”, which 
measures the ability of virally-infected cells to reactivate in vitro and form plaques on a 
permissive monolayer (Sunil-Chandra et al.1999 a & b; Cardin et al. 1996; Weck et al. 
1996). The establishment and the maintenance of latency are independent of infectious 
dose or route of infection (Tibbetts et al. 2003 a). Latency is established by virus 
traveling from the lung to the local lymph node [the mediastinal lymph node (MLN)], 
where dendritic cells, macrophages and B cells are infected. Dendritic cells are believed 
to be responsible for the initial transport of virus to the draining lymph node, where they 
seed B cells and establish latent infection (Nash et al. 2001). Upon the infection in the 
MLN, B cells undergo a rapid expansion accompanied by an increase in the number of 
latently infected B cells. B cells from the MLN then traffic to the spleen and other 
lymphoid organs and establishment of life-long latency takes place (Nash et al. 2001).  
Like in the EBV infection, B lymphocytes are the major reservoir harboring latent 
MHV-68 (Weck et al. 1996; Sunil-Chandra et al. 1992 b), although macrophages (Flano 
et al. 2000; Weck et al. 1999 b), splenic dendritic cells (Flano et al. 2000) and lung 
epithelial cells (Stewart et al. 1998) also have been shown to harbor latent infection. 
Memory B cells are the major reservoir for long term latency of MHV-68 (Flano et al. 
2002; Willer and Speck 2003) as well as of EBV (Babcock et al. 1997; Miyashita et al. 
1997).  
The establishment of latency in lymphoid tissue is characterized by a transient 
splenomegaly and lymph node enlargement that peaks 2-3 weeks post-infection (Fig. 
1.5). The transient splenomegaly phase resembles the infectious mononucleosis 
syndrome seen after EBV infection in adolescence. The hallmarks of this syndrome 
include splenomegaly, polyclonal B cell activation and associated autoantibody 
production, and a CD8+ T cell lymphocytosis in peripheral blood (Tripp et al. 1997; 
Blackman et al. 2000; Doherty et al. 1997; Sangster et al. 2000). Splenomegaly is due to 
increased numbers of cycling CD4+ T cells, CD8+ T cells and B cells in the spleen. 
Lymphocytosis in the peripheral blood is characterized by increased numbers of 
activated CD8+ T cells. The activated T cells in the peripheral blood are predominately 
CD8+  and express an CD62Llo-, CD44hi- activated phenotype with as many as 75% of 
the CD8+ T cells expressing Vβ4+TCR (Ehtisham et al. 1993; Sunil-Chandra et al. 1992 
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a & b; Tripp et al. 1997). There are however, key differences in the MHV-68 and EBV-
induced CD8+T cell responses. Whereas the expanded CD8+T cells associated with 
EBV-induced mononucleosis are largely the outgrowth of T cells responding to lytic 
viral epitopes elicited during the acute phase of the response, the CD8+T cell 
lymphocytosis associated with MHV-68-induced infectious mononucleosis is dominated 
by an oligoclonal population of T cells expressing Vβ4+T cell receptors that are not 
reactive to acute viral epitopes (as reviewed by Flano et al. 2002). 
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Fig. 1.5. Establishment of latency in the spleen of mice infected with MHV-68. Following i.n. 
infection, MHV-68 establishes latency in the spleen which is characterized by transient splenomegaly 
(dashed line) and amplification of latency, i.e., increase of the number of latently infected cells in the 
spleen (solid line).  
 
(modified from Stevenson et al. 2002 b) 
 
 
Also, during the transient splenomegaly phase, the amplification of latency takes place, 
i.e., the number of latently infected cells increases from 1 per 107 to 1 per 104 spleen 
cells (Fig. 1.5). Following the amplification of latency, the number of latently infected 
splenocytes decreases to 1 per 106 spleen cells by the third to fourth week post infection 
followed by the splenomegaly then decreasing back to a basal level (Sunil-Chandra et 
al. 1992 a; Usherwood et al. 1996 a). The rise and fall of the number of latently infected 
cells can be explained by the observation that, during the splenomegaly, many latently 
infected cells can be detected within germinal centers (GCs). As the B-cell response 
matures, GCs regress and there is a constant decline in the level of latency. Multiple 
immune mechanisms including CD8+ T cells, CD4+ T cells and antibodies contribute to 
the control of latency and prevent recrudescence of lytic virus (Christensen et al. 1999; 
Stevenson et al. 1999 b; Stewart et al. 1998). 
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The latent MHV-68 genome can be reactivated (i.e., emerge from latency) and enter the 
lytic phase of infection, but little is known about how latent reservoirs are maintained or 
which signals trigger reactivation from latency. Analogous to EBV and HHV-8, 
reactivation of MHV-68 ex vivo can be stimulated by the treatment of latently infected 
splenocytes with either anti-IgG-IgM and anti-CD40 or LPS (Moser et al. 2005). 
 
 
1.4.4. Pathogenesis 
 
Infection of adult mice with MHV-68 can lead to severe exudative pneumonia, 
vasculitis of the great arteries, infectious mononucleosis like syndrome and splenic 
fibrosis (Ehtisham et al. 1993; Sunil-Chandra et al. 1992 a; Usherwood et al. 1996 a; 
Weck et al. 1996). Chronic infection of mice with MHV-68 can lead to inflammation of 
large arteries, splenic fibrosis and fatal encephalitis in neonatal mice (Blaskovic et al. 
1980; Rajcani et al. 1985; 1987).  
It has been shown that gamma herpesviruses are associated with lymphoproliferative 
diseases of B and/or T cells. Additionally, EBV is associated with epithelial cancers, the 
most prominent is nasopharyngeal carcinoma (NPC), and HHV-8 is linked to vascular 
endotheliosarcomas such as Kaposi’s sarcoma. A striking property that is shared by 
many members of the gamma herpesvirus family, including EBV, HHV-8 and HVS is 
their ability to induce neoplasias in the natural or experimental hosts (Table. 1).  
It has been shown that MHV-68 infection can also lead to the development of tumors 
(Sunil-Chandra et al. 1994). However, these studies have not been reproduced by other 
groups. Balb/c mice infected with MHV-68 for period of nine months or longer have 
been shown to develop lymphomas and approximately 10% of infected mice developed 
tumors in both lymphoid and non-lymphoid tissues (lung, liver, kidney and heart). 50% 
of the lymphoid tumors were classified as high-grade lymphomas (Sunil-Chandra et al. 
1994). In another study, five cell lines were derived from persistently infected mice 
exhibiting lymphoproliferative disease (LPD); however, only one such line carried the 
virus genome (Usherwood et al. 1996 b). Transgenic expression of MHV-68 ORF 72 
(cyclin D homologue) in mice can also induce the development of high grade 
lymphoblastic lymphomas (van Dyk et al. 1999). 
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Table. 1. Malignancies associated with gamma herpesvirus infection.  
 
Daniel et al. 1974; 
Melendez et al. 1969
T-cell lymphomas in non-
natural host
Squirrel 
monkey
Herpesvirus saimiri
Parravicini et al. 1997Multicentric castleman’s 
disease
Cesarman et al. 1995; 
Nador et al. 1996
Primary effusion 
lymphomas
Beral et al. 1990Kaposi’s sarcomaHumanKaposi’s sarcoma-
associated herpesvirus
Imai et al. (1994)Gastric carcinoma
Wolf et al. (1973)Nasopharyngeal carcinoma
Ott et al. (1992)T-cell lymphomas
Purtilo (1985)X-linked 
lymphoproliferative 
syndrome
Gratama et al. (1988)Post-transplant lymphoma
Weiss et al. (1989)Hodgkin’s lymphoma
Facer and Playfair
(1989)
Burkitt’s lymphomaHumanEpstein-Barr virus
ReferencesAssociated malignanciesNatural HostGamma-herpesvirus
Primate gamma herpesviruses linked to neoplastic disease
 
 
 
1.4.5. Immune response to MHV-68 infection 
 
The immune system plays a very important role during gamma herpesvirus infection 
which is highlighted by the fact that most people worldwide are EBV carriers and 
normally remain asymptomatic unless they become immunocompromised, which 
exposes them to an increased risk of developing EBV-induced lymphoproliferative 
diseases and lymphomas (as reviewed by Penn 1986). In the case of MHV-68, both 
innate and adaptive immune responses are involved in recovery after infection as 
described below. 
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1.4.5.1. Role of B cells as host cells and in the immune response to MHV-
68 infection 
 
B cells play important roles in the MHV-68 infection, for example as a site of latency, 
spread of virus in the host, regulation of latency and control of chronic infection. MHV-
68 readily establishes latency in B cells, memory B cells and in germinal centers 
(Ehtisham et al. 1993; Flano et al. 2002; Bowden et al. 1997; Simas et al. 1999). The 
inefficient latent infection in the spleen after intranasal infection (Usherwood et al. 1996 
c; Weck et al. 1999 a; Willer and Speck 2003) and the inefficient acute infection in the 
spleen after intraperitoneal infection (Weck et al. 1996) in B cell deficient mice point to 
a role of B cells in the spread of virus through the host. 
As described above, B cells are host cells for MHV-68. In addition they play an 
important role in controlling the acute infection. B cell deficient mice have a continuous 
productive infection in the lung and die after prolonged infection with MHV-68 (Stewart 
et al. 1998; Weck et al. 1999 a). 
Induction of neutralizing antibodies can mediate an attenuated latent infection (Stewart 
et al. 1999). A direct role for protective antibodies (Abs) was demonstrated by the ability 
of passively transferred immune serum to prevent viral recrudescence in CD28-/- mice 
after T cell depletion (Kim et al. 2002). Finally, using reactivation deficient MHV-68 
for the vaccination, McClellan et al. have shown that an intact humoral response, even 
in the absence of CD4+ or CD8+ T cells, can provide protection against the 
establishment of latent infection in mice (McClellan et al. 2004). However, antibodies 
are apparently not essential for the resolution of acute infection (Cadrin et al. 1996; 
Usherwood et al. 1996 c; Ethisham et al. 1993).  
 
 
1.4.5.2. Role of CD4+ T cells in the immune response to MHV-68 infection 
 
CD4+ T cells are required for B cell proliferation, maturation, activation and antibody 
response (Stevenson and Doherty 1999; Sangster et al. 2000). The induction of 
splenomegaly after MHV-68 infection is driven by CD4+ T cells (Cardin et al. 1996; 
Usherwood et al. 1996 a). CD4+ T cells can resolve the acute infection, prevent lethal 
infection and inhibit the establishment of latency of MHV-68 in combination with CD8+ 
T cells (Ehtisham et al. 1993) or in the absence of CD8+ T cells (Christensen et al. 1999; 
 15
                                                                                                            Introduction 
McClellan et al. 2004; Stevenson et al. 1999 b). It has been found that in MHC class II 
knockout mice, there was little to no effect on clearance of acute infection of the lung 
and spleen. However, these mice were prone to recurrent virus infection in the lungs that 
is largely unresolved and progresses towards a chronic lung disorder (Cardin et al. 
1996). In agreement with EBV (Nikiforow et al. 2003), CD4+ T cells play an important 
role to contain the persistent MHV-68 infection (Tripp et al. 1997), probably by IFN-γ 
production (Christensen et al. 1999; Weck et al. 1997). Also, the ineffectiveness of 
antibodies and cytotoxic lymphocytes (CTLs) against lytic cycle proteins indicates the 
importance of CD4+ T cells in containing the persistent MHV-68 infection (Belz et al. 
2000; Liu et al. 1999; Stewart et al. 1999; Usherwood et al. 2001). 
 
 
1.4.5.3. Role of CD8+ T cells in the immune response to MHV-68 infection 
 
Similar to other gamma herpesviruses, CD8+ T cytotoxic lymphocytes play a major role 
in controlling MHV-68 acute infection. However, CD8+ T cells are not required for 
survival following acute infection depending on the mouse strain and the conditions of 
infection (Stevenson et al. 1999 b). Depletion of CD8+ T cells prior to infection results 
in a severe infection in the lung and dissemination of virus via the blood to infect spleen, 
liver and adrenal glands (Ehtisham et al. 1993). In BALB/c mice, MHV-68 infection 
after CD8+ T cell depletion can be lethal (Ehtisham et al. 1993; Stevenson et al. 1999 b). 
In C57BL/6 mice depleted of CD8+ T cells, acute infection in the lungs is still cleared, 
although the transient splenomegaly period is extended (Weck et al. 1996).  
One striking aspect of the response of CD8+ T cells to MHV-68 infection is the dramatic 
expansion of Vβ4+ CD8+ T cells (Tripp et al. 1997); however, the mechanism 
underlying this selective Vβ4+ T cells expansion and the physiologic importance of this 
phenomenon is currently undefined. It has been suggested that Vβ4+ CD8+ T cells can 
acquire effector function, including cytotoxicity and the capacity to secrete IFN-γ, 
although they have an atypical activation profile compared with well-characterized 
CD8+ T cells specific for conventional viral epitopes (Flano et al. 2004). 
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1.4.5.4. Role of cytokines and chemokines in the immune response to 
MHV-68 infection 
 
MHV-68 infection increases the expression of several chemokines and cytokines, which 
could potentially play important roles in controlling lytic and latent infection. MHV-68 
infection leads to the production of IL2, IL-6, IL-10 and IFN-γ (Sarawar et al. 1996). It 
has been shown that type I interferons (IFN α/β) play a key role in controlling acute 
viral replication and dissemination prior to the development of adaptive immunity 
(Dutia et al. 1997). Lack of the IFN-α/β receptor results in 100% mortality in mice 
within four days of MHV-68 infection (Weck et al. 1997). IFN-γ seems to be 
nonessential for clearance of an acute infection and control of latent virus following 
intranasal infection (Dutia et al. 1997; Sarawar et al. 1997); however, CD4+ T cell 
immunity is mediated by IFN-γ (Christensen et al. 1999). IL-6 is not essential for the 
development of an effective immune response to MHV-68 and does not influence viral 
replication and latency (Sarawar et al. 1998), whereas IL-10 has a dichotomous role, 
both in protection and pathogenesis (Peacock and Bost 2001). It has been demonstrated 
that the MHV-68 infection induces the expression of IL-12 in macrophages and 
dendritic cells and this cytokine plays an important role in the protective host response 
and in virus-induced splenomegaly (Elsawa and Bost 2004). 
It has been shown that the infection of mice with MHV-68 lead to an increase in the 
expression of RANTES, eotaxin, MIP-1α, MIP-1β, IP-10, KC, and MCP-1 by day 7 
post infection (Sarawar et al. 2002; Weinberg et al. 2002). It was proposed that 
chemokines play an important role in lymphocyte trafficking to the lung during the 
MHV-68 infection (Sarawar et al. 2002). 
 
 
1.4.6. Immune evasion by MHV-68 
 
MHV-68 infection leads to a massive proliferation of CD8+ T cells, which clear the lytic 
replication in the lungs with or without the help of CD4+ T cells. However, the T cell 
response is ineffective in preventing the massive proliferation of latently infected B cells 
in germinal centers, indicating the existence of immune evasion by MHV-68. This 
amplification and lymphoproliferation is accompanied by antigen-nonspecific B cell 
activation which is important for host colonization (Stevenson 2002 a & b; 2004). 
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Gamma herpesviruses encode several proteins (HSV, ICP47; HCMV, pp65, US6, US11, 
US2, US3; EBV, EBNA-1; HHV-8, K3, K5; MHV-68, MK3, M3) that play a role in 
immune evasion (as reviewed by Alcami and Koszinowski 2000; Hegde et al. 2003; 
McFadden et al. 1996; Ploegh 1998; Yewdell and Hill 2002). So far two immune 
evasion genes (M3 and MK3) have been identified in MHV-68.  
 
 
1.4.6.1. Immune evasion mediated by the M3 protein of MHV-68 
 
Herpesviruses encode a variety of proteins with the potential to disrupt chemokine 
signaling, and hence immune organization (Alcami and Koszinowski 2000; Lalani et al. 
2000). The MHV-68 M3 gene encodes a secreted 44-kD broad spectrum chemokine-
binding protein that neutralizes cellular responses to a broad spectrum of chemokines in 
vitro (Parry et al. 2000; van Berkel et al. 2002). The M3 protein has no sequence 
similarity to known chemokine receptors. It binds CC, CXC, C, and CX3C chemokines, 
but does not bind human B-cell specific nor mouse neutrophil-specific CXC chemokines 
(van Berkel et al. 2002). In vivo, disruption of M3 has little effect on lytic replication or 
the initial spread of virus to lymphoid tissues. However, there is no amplification of 
latently infected B cells in the spleen that normally drives MHV-68-induced infectious 
mononucleosis and a marked reduction in latent virus load is observed. This defect in 
the amplification of latency was largely reversible by CD8+ T cell depletion (Bridgeman 
et al. 2001).  
 
 
1.4.6.2. Immune evasion mediated by the MK3 protein of MHV-68 
 
A major arm of host immunity to viral infection are cytotoxic T lymphocytes (CTL), 
which recognize viral antigens presented as peptides bound to MHC class I molecules 
on the surface of infected cells. Therefore, evasion of CTL recognition is thought to play 
a key role in the establishment of systemic viral infection. Many viruses including the 
herpesviruses have evolved complex strategies for such evasion, usually centering on 
down-regulation of cell surface MHC class I display (Boname et al. 2004 a; Coscoy et 
al. 2001; Coscoy and Ganem 2000; Hewitt et al. 2002; Ishido et al. 2000; Lorenzo et al. 
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2002; Stevenson et al. 1999a; 2002 a).  Both MHV-68 and HHV-8 encode membrane 
bound Ring finger proteins that act as E3 ubiquitin ligases for MHC class I called MK3, 
K3 and K5. The HHV-8 proteins K3 and K5 act late in the secretory pathway and direct 
MHC class I to lysosomes (Coscoy and Ganem 2000; Hewitt et al. 2002; Ishido et al. 
2000; Lorenzo et al. 2002). The MHV-68 MK3 protein remains in the endoplasmic 
reticulum (ER) and ubiquitinates MHC class I heavy chains that associate with the 
transporter associated with antigen processing (TAP), leading to proteasome-dependent 
degradation (Lybarger et al. 2003). The association of MK3 with the peptide-loading 
complex also allows it to degrade TAP, thereby broadening its inhibitory repertoire to 
include peptide loading of non-classical MHC class I glycoproteins with short or absent 
cytoplasmic tails that are not accessible to ubiquitination (Boname et al. 2004 a). The 
TAP degradation by the MK3 protein also provides a remarkable resistance to MHC 
class I up-regulation by IFN-γ (Boname et al. 2004 a). In vivo, the infection of mice with 
mutant virus for MK3 protein has little effect on lytic replication in the lungs. However, 
the disruption of the MK3 protein leads to enhanced antiviral CTL responses, impaired 
expansion of latently infected cells in lymphoid germinal centers and an attenuation of 
the MHV-68-induced infectious mononucleosis. This defect in the amplification of 
latency was largely reversible by CD8+ T cell depletion as now the MHC class I 
dependent defense has disappeared (Stevenson et al. 2002 a). 
Both the MK3 and M3 genes are transcribed during acute lytic infection in the lung as 
well as during establishment of latency in lymphoid tissue. The tissue damage caused by 
productive MHV-68 replication is presumably a potent inflammatory stimulus and 
therefore, the immune activation overcomes the immune evasion mediated by MK3 or 
M3, an effect that is well documented with other herpesviruses (Hengel et al. 1999; 
Posavad et al. 1998). Latent virus, unlike lytic replication, probably causes minimal 
tissue disruption, and in this setting, evasion seems to be dominant. Also, during the 
viral reactivation, when tissue damage will be minimal, the MK3 expression may 
contribute to immune evasion (Stevenson et al. 2002 b). 
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1.4.7. Exploring vaccination strategies against gamma herpesviruses 
using the MHV-68 system 
 
Due to the species specificity of the human gamma herpesviruses, strategies for 
vaccinating against human gamma herpesviruses have been difficult to study. Therefore, 
several groups have used MHV-68 infection of mice as an important model in defining 
novel vaccination strategies against human and animal gamma herpesviruses (Belz et al. 
2000; Liu et al. 1999; Stevenson et al. 1999; Stewart et al. 1999; Usherwood et al. 
2001). Several vaccination studies have demonstrated effective reduction in both acute 
infection and early forms of latency. Vaccination against the lytic cycle protein peptide 
epitopes ORF6487-495/Db and ORF61425-531/Kb and latency-associated antigen M2 induces 
strong CD8+ T-cell responses and significantly reduces acute infection and early latency 
(Belz et al. 2000; Liu et al. 1999; Stewart et al. 1999). Vaccination against the cell 
membrane and virus particle antigen gp150 induces neutralizing antibody and reduces 
acute infection and early stages of latency (Liu et al. 1999; Stewart et al. 1999). Despite 
the effectiveness of these strategies against acute infection and/or early latency, none 
was effective against MHV-68 latency beyond 20 days of infection.  
In contrast to MHV-68 proteins or peptide vaccines, latency or reactivation-deficient 
MHV-68 viruses serve as better vaccines, and it has been shown that they largely 
prevent subsequent wild type latency establishment (Boname et al. 2004 b; Fowler and 
Efstathiou 2004; McClellan et al. 2004; Tibbetts et al. 2003 b). Using reactivation-
deficient MHV-68 as vaccine, McClellan et al. have shown that CD4+ T cells play a 
critical role in immune surveillance of gamma herpesvirus latency and can mediate 
vaccination against latency, even in the absence of an antibody response (McClellan et 
al. 2004). Therefore, successful vaccination strategies against gamma herpesviruses will 
depend upon defining the molecular mechanism that underlie vaccine-induced 
protection, in particular the potential of CD4+ T cells to control in vivo MHV-68 latency 
(Stevenson 2004). 
 
No sequence homologues to the EBV latency and transformation-associated proteins 
[EBV nuclear antigens (EBNAs), latent membrane protein 1 and 2 (LMP-1 and 2)] or 
the EBV-encoded transactivator, BZLF-1, are present in the genome of MHV-68 (Simas 
and Efstathiou 1998). Yet, the similarities of MHV-68 to other gamma herpesviruses in 
terms of its genomic organization, pathological symptoms and the establishment of both 
lytic and latent phase of infection, provide a valuable tool to study gamma herpesvirus 
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pathogenesis and immunity. The strength of this model lies in its capacity to reproduce 
key common features of gamma herpesvirus infection in a natural host, including 
primary lytic replication, latency establishment and maintenance, and viral reactivation. 
This, combined with the availability of genetically defined mice and the capacity to 
manipulate the MHV-68 genome, provides the basis for the comprehensive description 
of gamma herpesvirus biology. 
 
 
1.5. Aim of the project 
 
One of the characteristics of gamma herpesviruses is the presence of various kinds of 
internal repeats in their genome. The human herpesviruses, EBV and HHV-8, possess 
internal repeats of different numbers and size in their genome; however, it is not known 
if variations in the number of repeats play a role in the pathogenesis. In vitro, internal 
repeats (IR) of EBV (IR2) and IR 4 are part of an origin of lytic replication (ori Lyt) and 
in addition, these repeats contain enhancer-like sequences (Cox et al. 1990; 
Hammerschmidt and Sugden 1988). Also, some of the repeats of the HHV-8 and MHV-
68 genome are part of an ori Lyt, and these repeat structures act as an auxiliary element 
to enhance replication efficiency (AuCoin et al. 2002; Deng et al. 2004). The internal 
repeats of the herpes simplex virus play an important role in pathogenesis. Loss of the 
internal repeat resulted in lower virulence, a decreased spread of virus from the cornea 
to sensory ganglia and a decreased establishment of reactivable latent virus in the 
trigeminal ganglion (Jenkins et al. 1996). 
MHV-68 also contains two internal repeats in its genome, i.e., the 40 bp repeat and 100 
bp repeat. The presence of these internal repeats in the genome of MHV-68 provides an 
opportunity to address the role of these repeats in gamma herpesvirus pathogenesis. The 
100 bp repeat is present at the right side of the genome (nucleotide positions 98981- 
101170) and consists of approximately 21 copies of 100 bp repeat units. The 100 bp 
repeat is a part of three overlapping ORFs: ORF M10a, ORF M10b and ORF M10c. In 
addition, the 100 bp repeat contributes to the lytic origin of replication at the right side 
of the MHV-68 genome (Deng et al. 2004). The 40 bp internal repeat of MHV-68 is 
present at the left side of the genome (nucleotide positions 26778-28191). It consists of 
approximately 36 copies of repeat units, some of which can vary in their sequence 
(Virgin et al. 1997) (Fig. 1.6). 
 21
                                                                                                            Introduction 
A A A A A A A A A A A A C B C D E E
Type A repeat – 40mer with Bam HI site
CCGACCTCCC CGGCCCCTC CCGAGCTGGG GCCCGGATCC
Type B repeat – 41mer with Bam HI site
CC C GACCTCC CGGCCCCTC CCGAGCTGGG GCCCGGATCC
Type C repeat – 41mer with Bam HI site
CC C GACCT TC CGGCCCCTC CCGAGCTGGG GCCCGGATCC
Type D repeat – 51mer with Bam HI site
CCCCGGTTCC CC C GACCT TC CGGCCCCTC CCGAGCTGGG GCCCGGATCC 
Type E repeat – 41mer without Bam HI site
CC C GACCTCCC CGGCCCCTC CCGAGCTGGG GCCCGGTTCC
 
 
Fig. 1.6. Organization and sequence of the 40 bp internal repeat present in the MHV-68 genome. 
The 40 bp repeat is estimated to contain 27 copies of a type A repeat units, linked to several degenerated 
forms of the repeat located at the right-hand end (type B to E repeats), as illustrated. The sequence of each 
type of repeat is shown below the schematic diagram of the repeat structure. Residues which differ from 
the type A repeat are underlined, and the presence of BamH I sites is indicated by open rectangles. 
 
(modified from Virgin et al. 1997) 
 
 
Although the complete sequence of MHV-68 has been determined, the precise role of 
many viral genes or family of genes is not well known. One way to determine the 
function of a viral gene in the context of the whole viral genome is mutagenesis of the 
gene of interest. Recently, MHV-68 genomic DNA was cloned as a bacterial artificial 
chromosome (BAC) (Adler et al. 2000; 2001; 2003), which provides an efficient, fast 
and valuable tool for mutagenesis. However, during mutagenesis, many clones lose 
some of their 40 bp internal repeat units, due to recombination between direct repeats. 
These size variations due to alterations in the repeat structures also occur naturally in 
other gamma herpes viruses. Therefore, it is interesting to determine whether the 
variability of the MHV-68 internal repeat structures has any biological effect in vivo.  
It has been suggested that MHV-68 can be used for the development of amplicon 
vectors (Deng et al. 2004). Since the 40 bp internal repeat and its neighbouring region in 
the MHV-68 genome might contain a lytic origin of replication (Coleman et al. 2004), it 
is critical to define and check the stability of putative origin of lytic replication 
sequences required for viral DNA replication and packaging. This will help to define the 
parameters for the development of MHV-68-based amplicon vectors.  
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The 40 bp internal repeat is also a part of the hypothetical ORF M6. Micro-array 
analysis (Ahn et al. 2002) and genome sequencing of MHV-68 (Virgin et al. 1997) 
predicted the existence of ORF M6, however, it was also proposed that  it is unlikely to 
encode for any protein (Nash et al. 2001; Ebrahimi et al. 2003). Therefore, it is 
important to define the existence of ORF M6 protein expression. 
We used infection of mice with murine gamma herpesvirus-68 (MHV-68) as a small 
animal model to study the biological significance of the 40 bp internal repeat and/or 
ORF M6 of MHV-68 both in vitro and in vivo. In order to achieve this goal, we carried 
out the following steps: 
 
A) Construction of the 40 bp repeat and ORF M6 mutant viruses 
6 independent virus mutants were constructed to determine the role of the 40 bp repeat 
and/or ORF M6 in the context of the whole MHV-68 genome. 
 
B) In vitro characterization of the 40 bp repeat and ORF M6 mutants  
The in vitro characterization of the 40 bp and ORF M6 mutants was carried out by 
analyzing their growth properties in cell culture. 
 
C) In vivo characterization of the 40 bp repeat and ORF M6 mutants  
Mice were infected with the mutant viruses and their phenotype was analyzed in vivo by 
determining different parameters including lytic virus titers in the lung, spleen weight 
and ex vivo reactivation. 
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2.0 Materials  
 
2.1. Bacterial strains 
 
E. coli DH10B F-, mcrA, (mrr-hsdRMS-mcrBC), Φ80dlacZΔM15, 
ΔlacX74,deoR, recA1, endA1, araD139, Δ(ara, leu)7697, 
galU, galK, λ-, rpsL, nupG, used for propagation and 
recombination of MHV-68 BAC. 
E. coli JC8679           rec BC, sbc A, used for ET cloning 
 
 
2.2. Existing cell lines 
 
293  Human embryonic kidney epithelial cell line 
                                                         (Graham et al. 1977) 
Ag8 Mouse B cell line (ATCC No. CRL-1580) 
BHK-21  Baby hamster kidney cell line (ATCC No. CCL-10) 
NIH 3T3 Mouse fibroblast cell line (ATCC No. CRL-1658) 
Ref/Cre  rat embryonal fibroblast cell line expressing Cre 
recombinase 
 
 
2.3. Mice strains 
 
C57BL/6 wild type  Charles River Laboratory, Sulzfeld, Germany 
C57BL/6 wild type  Jackson Laboratory, Bar Harbor, ME, USA 
C57BL/6 β2 micoglobulin-/- Jackson Laboratory, Bar Harbor, ME, USA 
C57BL/6 CD8-/- Jackson Laboratory, Bar Harbor, ME, USA 
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2.4. Materials used for mice maintenance, anesthesia 
 
Autoclaved chow   
Ketamine/Xylazine  
 
 
2.5. Materials for bacterial and eucaryotic cell culture 
2.5.1. Microbial nutrients 
 
Bacto-agar Invitrogen, Germany 
Bacto-tryptone Invitrogen, Germany  
Bacto-yeast extract Invitrogen, Germany 
 
 
2.5.2. Growth media and accessories for mammalian cell culture and 
transfection 
 
DMEM High Glucose  
Medium  Invitrogen, Germany 
Foetal calf serum Invitrogen/Gibco, Germany 
Glasgow`s MEM (GIBCO) Biochrom AG, Germany 
HEPES Invitrogen, Germany 
L-glutamine Invitrogen, Germany 
RPMI - 1640 medium Invitrogen, Germany 
Superfect transfection reagent Qiagen, Germany 
 
 
2.5.3. Antibiotics 
 
Ampicillin Sigma-Aldrich, USA 
Chloramphenicol Sigma-Aldrich, USA 
Kanamycin Sigma-Aldrich, USA  
Penicillin/Streptomycin Invitrogen, Germany 
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2.6. Plasmids 
2.6.1. Existing plasmids used during this work 
 
pST 76 K-SR                             shuttle plasmid, used for mutagenesis of MHV-68  
                                                     (Adler et al. 2003) 
pUC19                                       a small, high copy number E. coli plasmid  
MHV-68 BAC                          MHV-68 genome, cloned as BAC  
                                                    (Adler et al. 2003) 
 
 
2.6.2. Plasmids produced during the course of this work 
 
pST 76 derived plasmids: 
pST 76 K-SR M6  a pST 76 K-SR derivative plasmid containing a Sma 
I fragment of MHV-68 (nucleotide position 24918-
30834) 
pST 76K-SR M6 Stop a pST 76K-SR derived plasmid containing a stop 
codon in all three frames of ORF M6 at Hind III site 
in MHV-68 genome (nucleotide position 26711)  
pST 76 K-SR M6 Point a pUC 19 derived plasmid containing a point 
mutation (ATG to ACG) in the start codon of ORF 
M6 in MHV-68 genome (nucleotide position 26555) 
pST 76K-SR M6 Stop+ Point a pUC 19 derived plasmid containing a point 
mutation in the start codon (nucleotide position 
26555) as well as stop codon in all the three possible 
frames of ORF M6 in MHV-68 genome (nucleotide 
position 26711) 
 
pUC19 derived plasmids 
pUC 19 (Hind III negative) a pUC 19 derivative plasmid without the restriction 
enzyme Hind III site in its multiple cloning site.  
pUC 19 M6  a pUC 19 derived plasmid containing 5.237 kbps 
Kpn I- Nde I  (containing the 40 bp internal repeat) 
fragment from pST76K-SR M6.  
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pUC19 M6 Stop  a pUC 19 derived plasmid containing a stop codon 
in all three frames of ORF M6 at Hind III site in 
MHV-68 genome (nucleotide position 26711)  
pUC 19 M6 Point  a pUC 19 derived plasmid containing a point 
mutation (ATG to ACG) in the start codon of ORF 
M6 in MHV-68 genome (nucleotide position 26555) 
pUC19 M6 Stop + Point a pUC 19 derived plasmid containing a point 
mutation in the start codon as well as stop codon in 
all the three possible frames of ORF M6 in MHV-68 
genome (nucleotide position 26711) 
 
 
MHV-68 BAC derived plasmid 
 
40 bp mutant BAC plasmid  a MHV-68 derived BAC plasmid without the 40 bp 
internal repeats (nucleotide position 26778-28191) 
M6 Stop BAC mutant a pST 76K-SR derived BAC plasmid containing a 
stop codon in all three frames of ORF M6 at Hind III 
site in MHV-68 genome (nucleotide position 26711) 
M6 Point BAC mutant       a pST 76K-SR derived BAC plasmid containing a 
point mutation (ATG to ACG) in the start codon of 
ORF M6 in MHV-68 genome (nucleotide position 
26555) 
M6 Stop+ Point BAC mutant a pST 76K-SR derived BAC plasmid containing a 
point mutation in the start codon as well as stop 
codons in all three possible reading frames of ORF 
M6 in MHV-68 genome 
 
 
2.7. Oligonucleotides 
 
All oligonucleotides were manufactured by Metabion GmbH, Germany 
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2.7.1. Primers used for estimation of genomic load in splenocytes 
 
ORF 50 (MHV-68 open reading frame 50) 
LDAPCRin1            5`- CCC CAA TGG TTC ATA AGT GG -´3 
LDAPCRin2       5’- ATC AGC ACG CCA TCA ACA TC -`3 
 
 
rpl8 (ribosomal protein l8) 
rpl Forward         5’- CAG TGA ATA TCG GCA ATG TTT TG -`3 
rpl Reverse            5’- TTC ACT CGA GTC TTC TTG GTC TC  -`3 
 
K3 (MHV-68 K3 gene) 
K3 for                  5’- GAG AGT TCT GTT GGA TCT GC -3’ 
K3 Rev               5’- GTC GCG ATC GCC TCA TCA ATG -3’ 
 
eF1β (elongation factor 1β) 
eF1 β for      5’- TTA CCT GGC GGA CAA GAG CT-3’ 
eF1 β rev 5’- CCA ATT TAG AGG AGC CCC ACA-3’ 
 
GAPDH (Glyceraldehyde Phosphate Dehydrogenase) 
GAPDH for                       5’- CTC ACT CAA GAT TGT CAG CAA TG-3’ 
GAPDH rev                         5’- GAG GGA GAT GCT CAG TGT TGG-3’ 
 
 
2.7.2. Primers used for the generation of mutations in the ORF M6 
region of pUC19 M6  
 
pUC19 M6 Stop     
M6 Stop for          5’- AAT ATA AAC TCG AGG CGG CAA GG-3` 
M6 Stop rev         5’- TAT AGA AAG CTT CTA GTT AAC TAG 
TTA TAT CAG AAT AAA AC-3’ 
pUC19 M6 Point   
M6 point for1            5’-AAT ATA AAC TCG AGG CGG CAA GG-3’  
M6 point rev1           5’ TGC CGT CCT GTA TAC CCA TTT TG-3’ 
M6 Point for 2           5’CAG GAC GGC ACA CAC CAA C-3’ 
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M6 Point rev2            5’ AAG CTC GTG AAA GCT TTT ATA TCA 
GAA TAA-3’ 
 
 
2.7.3. Primers used for ET cloning to generate 40 bp BAC mutant 
 
40 bp mut for      5’- TCT GGG TCA TTT TGG TTT TGT TCC TCG 
ACC TGT GCG GAT CGT TTT GGG TTC CAG 
GGT TTT CCC AGT CAC GAC GT-3’ 
40 bp mut rev    5’- TGA GAT GAC TTT GTG ACA GGT CCC 
AGC TCG GGC GAG GGC CGG GAA GGT GGC 
ACA GGA AAC AGC TAT GAC CAT GA -3’ 
 
 
2.7.4. Primers used for verification of mutations in the ORF M6 region 
 
M6 seq. for         5’-ATC GAT ATC TCC CCT GAA GC-3’ 
M6 seq. rev        5’- ACA GGT CGA GGA ACA AAA C-3’ 
B5 NTBAC        5’-TCG ACC TGT GCGGATCG-3’ 
 
 
2.8. Antibodies 
 
Mouse anti-DIG antibody, AP conjugated (Roche Diagnostics GmbH, Germany) 
The following antibodies were purchased from Pharmingen, USA 
FITC anti mouse CD3 
FITC anti mouse CD4 
FITC anti mouse CD45R/B220 
FITC anti mouse CD8a (Ly-2) 
FITC mouse IgG2b
PE anti mouse Vβ4 T-cell Receptor 
PE mouse IgG2b 
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2.9. Enzymes 
 
Alkaline shrimp phosphatase Roche Diagnostics GmbH,Germany 
DNA endonucleases  New England Biolabs, USA;  
Klenow fragment Roche Diagnostics GmbH, German 
Proteinase K Sigma-Aldrich GmbH, Germany 
Pwo DNA polymerase Roche Diagnostics GmbH, Germany 
RNAse A Sigma-Aldrich GmbH, Germany 
T4-DNA ligase New England Biolabs, USA 
Taq DNA polymerase PeqLab, Germany 
 
 
2.10. Commercial kits 
 
DIG DNA Labeling kit                    Roche Diagnostics GmbH, Germany 
LightCycler-FastStart                    Roche Diagnostics GmbH, Germany 
Gel Purification kit   Amersham Biosciences, Germany 
 
 
2.11. Materials or reagents used for molecular biology techniques 
 
Agarose                                 Invitrogen, Germany 
Bovine serum albumin New England Biolabs, USA 
DIG DNA labelling mix Roche Diagnostics GmbH, Germany 
DNA ladders Invitrogen, Germany  
dNTP Roche Diagnostics GmbH, Germany 
Ethidium-Bromide Merck KG, Germany 
 
 
2.12. Plates, flasks and tubes for cell culture 
 
Falcon tubes (15 and 50 ml)  Becton Dickinson 
Tissue culture flask  
(25, 75 and 150 cm2) TPP, Switzerland 
Tissue culture plates  
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(6, 24 and 96 well plates)                TPP, Switzerland 
Pippetes (25, 10 and 5 ml)               Greiner bio-one, Switzerland 
 
 
2.13. Other materials 
 
Gel-Blotting paper Schleicher & Schuell, Germany 
Cell culture plates and flasks Nunc, Germany 
Electroporation cuvettes (2,4 mm)  Bio-Rad Laboratories, UK 
Filter , 0.45 μm, 0.2 μm Sartorius, Germany 
Filter, 0.8 μm Renner GmbH, Germany 
Hybond N+ PVDF membrane Amersham Bioscience, Sweden 
Uni-Filter 96 GF/C Packard Biosciences Germany  
X-ray film (Biomax MS)                 Eastman Kodak Co, USA 
 
 
2.14. Laboratory equipment 
 
Bacterial incubator Heraeus Instruments, Germany 
Bacterial shaker C25 New Brunswick Scientific, USA 
Centrifuge 2K15 Sigma Centrifuges GmbH, Germany 
Centrifuge 35R Hettich, Germany 
Centrifuge 5415D Eppendorf, Germany 
Centrifuge, 5417R Eppendorf, Germany 
Centrifuge 6K10 Sigma Centrifuges GmbH, Germany 
Centrifuge EBA12 Hettich, Germany 
Centrifuge HSP 9 Heraeus, Germany 
Centrifuge RC5C Sorvall Instruments, USA 
Electroporator Bio-Rad Laboratories, USA 
Electroporator PEQLABBiotechnologieGmbH, Germany 
Freezer -20 oC  Liebherr, Germany 
Freezer -80 oC  Thermo-Lifesciences, Germany 
Freezer 4 oC  Bosch, Germany 
Flow cytometer Beckton-Dickinson GmbH, Germany 
Flow hood work bench Heraeus Instruments, Germany 
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Gel electrophoresis power supply Biometra, Germany 
Gel electrophoresis units  Amersham Bioscence, Sweden 
Gel electrophoresis unit  Biometra, Germany 
Hybaid hybridization oven  MWG Biotech, Germany 
Light Microscope Zeiss, Germany 
LightCycler  Roche Diognostics GmbH, Germany 
Mammalian cell incubator Heraeus Instruments, Germany 
PCR System Eppendorf, Germany 
Power X-ray film developer Eastman Kodak Company, USA 
Spectrophotometer Biometra GmbH, Germany 
Speed-vac, concentrator SVC100 Savant, USA 
Thermomixer 5436 Eppendorf, Germany 
Thermomixer comfort Eppendorf, Germany 
Ultracentrifuge L7-55, L8-70M Beckman, USA 
UV transilluminator PeqLab, Germany 
Water purification system Millipore GmbH, Germany 
Water Bath GFL, Germany 
 
 32
                                                                                                                   Methods 
3.0 Methods 
 
The standard molecular biology techniques used in this work were performed according 
to the protocols described (Sambrook and Russell 2001). 
 
 
3.1. Bacterial cell culture 
 
3.1.1. Maintenance and propagation of bacteria 
 
LB agar plates and LB liquid medium were used to cultivate bacteria. To isolate single 
colonies of bacteria of interest, bacteria were cultured overnight on LB plates with or 
without antibiotics. For propagation of single clones, single colonies were cultured in 
appropriate volume snapcaps or culture flasks in LB medium in a bacterial shaker at 
37°C for approximately 16-18 hours. Appropriate antibiotics were added to the culture 
medium as indicated. The final concentrations of antibiotics were: ampicillin; 100 
μg/ml, kanamycin; 25 μg/ml, chloramphenicol; 30 μg/ml. For long-term storage, dense 
bacterial pellets were stored frozen in deep freeze vials at -80°C in growth media with 
15% glycerol. 
 
LB-medium: 20 mM MgSO4; 10 mM KCl; 1% (w/v) Bacto-
Tryptone; 0.5% (w/v) Bacto-yeast extract; 0.5% 
(w/v) NaCl 
LB-agar: LB-medium, 1.5% (w/v) Bacto-agar 
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3.1.2. Preparation of competent bacteria 
3.1.2.1. Preparation of competent bacteria for electroporation 
 
Relevant bacteria were plated out on LB plates to obtain single colonies. A single 
colony from the culture plate was inoculated in 5 ml of LB media with or without 
antibiotics and cultured overnight in a shaking incubator. 2 ml from this overnight 
culture were used for inoculation of 500 ml LB medium with or without antibiotics and 
cultured at 37°C. Bacterial cultures were grown to an optical density of 0.5 to 0.7 and 
then kept on ice for 10-15 min. Bacteria were then pelleted at 4200 rpm for 20 min at 
4°C and resuspended in 250 ml of chilled H2O. After a second centrifugation with 
similar conditions, the bacterial pellet was resuspended in ice cold 200 ml of 0.2 mM 
Hepes (pH 7.5) solution. A third round of centrifugation was performed, and the pelleted 
bacteria were resuspended in 10 ml of 15% cold glycerol. After a final centrifugation 
step, the bacterial pellet was resuspended in 4-5 ml of 10% cold glycerol. This 
suspension was frozen down to -80°C in 50 μl aliquots for use in electroporation.  
 
 
3.1.2.2. Preparation of competent bacteria for heat shock transformation 
 
Competent bacteria were prepared following the protocol of Sambrook, Fritsch and 
Maniatis (page 1.82). Briefly, a single colony from a LB-plate was used to inoculate 5 
ml of LB-medium and cultured overnight in a shaking incubator. 1 ml of this overnight 
culture was used to inoculate 200 ml of LB-medium. Bacteria were grown in a 1 l flask, 
with shaking, at 37°C until the absorbance at 600 nm reached 0.5 to 0.7. After 
harvesting, bacteria were kept on ice for 10 min and pelleted at 3500 rpm, 20 minutes at 
4°C. The medium was discarded and the bacteria resuspended in 20 ml of ice-cold 0.1 
M CaCl2. The cells were then pelleted at 3500 rpm for 20 minutes at 4°C and 
resuspended in 4 ml of ice-cold 0.1 M CaCl2. Another round of centrifugation was done 
and finally the cells were resuspended in 2 ml of 10% cold glycerol and frozen 
immediately at -80°C in 50 µl aliquots. 
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3.1.3. Transformation of bacteria  
3.1.3.1. Heat shock transformation  
 
50 μl competent bacteria were thawed on ice, mixed with 10-100 ng of plasmid DNA or 
10 μl of ligation mixture and incubated on ice for 30 min. The bacteria-DNA mix was 
then subjected to heat shock at 42°C for 2 min and transferred to ice for 5 minutes. 500 
μl LB-medium was supplied and the sample incubated at 37°C for 1h. Different 
amounts of the sample (20-300 μl) were plated onto LB-agar plates containing the 
appropriate antibiotic. The LB-agar plates were incubated at 30 or 37°C for 16-18 hours 
after which single colonies growing out could be observed.  
 
 
3.1.3.2. Transformation using electroporation 
 
50 μl of electro-competent bacteria were mixed with 10-100 ng of plasmid DNA and 
incubated for 5-10 minutes on ice. The cells were subjected to electric shock in a 
BioRad electroporator at 2500 V and 335 Ω in a 2 mm cuvette and transferred to ice for 
1 minute. 500 μl of LB-medium was then added to the sample and incubated at 30-37°C 
for 1 hour. Different amounts of bacterial suspension were plated onto LB-agar plates 
containing appropriate antibiotics. The LB-agar plates were incubated at 30-37°C for 
16-18 hours. 
 
 
3.1.4. Isolation of plasmid  
3.1.4.1. Small-scale plasmid DNA isolation (minipreps) 
 
Bacteria carrying the correctly cloned constructs were identified after small scale 
plasmid DNA isolation. For this purpose, 1 ml overnight single clone bacterial cultures 
were centrifuged at 14000 rpm for 1 minute in 1.5 ml eppendorf microcentrifuge tubes. 
The supernatant was discarded and the pellet resuspended in 200 µl of solution I to 
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obtain a homogenous suspension. Bacteria were lysed by the slow addition of 200 µl of 
solution II with gentle mixing by inversion of the tube for a few times. Following 5 
minutes incubation at room temperature, 400 µl of solution III was added and the tubes 
were incubated on ice after gentle swirling to obtain a gelatinous mass of precipitate. 
The samples were then centrifuged at 14000 rpm for 10 minutes to pellet down the 
debris and the supernatant was collected in a fresh tube. Absolute ethanol was added to 
this supernatant to a final concentration of 60% and the DNA was precipitated by 
centrifugation at 14000 rpm for 10 minutes at 4°C. The supernatant was carefully 
discarded so as to retain the pellet which was then washed with 70% ethanol by 
resuspension of the pellet and centrifugation for 5 minutes at conditions as for the 
previous step. The pellet finally obtained by discarding the supernatant was allowed to 
air dry and resuspended in 50 µl of 1 X TE. 
 
Solution I: 50 mM glucose; 10 mM EDTA; 25 mM Tris-HCl 
pH 8.0 
Solution II: 0.2 M NaOH; 1% SDS 
Solution III: 3.1 M K-acetate (pH 5.5) 
1 X TE: 10 mM Tris-HCl-1 mM EDTA (pH 7.5) 
 
 
3.1.4.2. Small-scale preparation of highly pure plasmid DNA  
 
To obtain highly pure plasmid DNA for sequencing, restriction enzyme analysis and 
transformation a small scale preparation of plasmids was carried out using the GFXTM 
Micro Plasmid Prep Kit (Amersham Biosciences, Sweden). Briefly, 1.5 ml of overnight 
bacterial culture was spun down and resuspended in solution I followed by lysis with 
solution II and neutralised by solution III. The cell debris was pelleted down by 
centrifugation at 14000 rpm for 5 minutes, and the plasmid-containing supernatant was 
loaded onto a GFX column. After loading the plasmid containing solution onto the 
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column, one round of washing with wash buffer was done and finally the plasmid DNA 
was eluted in 100 µl of 1 X TE. 
3.1.4.3. Large-scale preparation of plasmid DNA 
 
Large scale plasmid preparation was carried out using the Qiagen Maxi Kit 25. Briefly, 
a 300 ml overnight culture was spun down and the pellet was resuspended in 10 ml of 
solution P1. SDS alkaline lysis of the bacteria was done with 10 ml of solution P2 and 
the lysate was neutralised with 10 ml of neutralisation solution P3. The neutralised 
lysate was centrifuged at 20,000 x g for 30 minutes at 4°C. Then, the clear supernatant 
was transferred onto equilibrated silica columns optimised for plasmid DNA binding 
and washed with buffer QC. Bound plasmid DNA was eluted with the elution solution 
(QF) and the DNA in the eluate was acquired by precipitation with l0.5 ml of 
isopropanol. The supernatant was carefully discarded so as to retain the pellet and the 
pellet was washed with 70% ethanol and resuspended in 1 X TE. Purity of the plasmid 
DNA was assessed by measuring the 260 nm/280 nm absorption ratio. The plasmid was 
analysed by multiple restriction enzyme digestions and sequenced where indicated. 
 
 
3.1.4.4. Small-scale BAC plasmid isolation 
 
For the screening of BAC clones, a small scale BAC plasmid preparation was 
completed. 10 ml overnight bacterial cultures were spun down by centrifugation at 3500 
rpm for 10 minutes and the pellet was resuspended in 200 μl of solution I (Qiagen Maxi 
Kit 25). 200 μl of solution II was then slowly added to the suspension and the samples 
were gently mixed by inverting a few times. Following 5 minute incubation at room 
temperature, 200 μl of solution III was added and the tubes were incubated on ice for 10 
minutes after gentle swirling to obtain a gelatinous mass of precipitate. The samples 
were then centrifuged at 14000 rpm for 10 minutes at 4˚C to pellet down the debris and 
the supernatant was collected by transferring to a fresh tube. An equal volume of 
phenol: chloroform: isoamylalcohol (IAA) (25:24:1) was added to the samples and 
mixed well by inverting for 10 minutes. The aqueous phase containing the plasmid was 
separated from the phenol chloroform phase by centrifugation at 14000 rpm for 10 min. 
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The aqueous phase was transferred to a new eppendorf tube. 1 ml of isopropanol was 
added and the plasmid DNA was precipitated by centrifugation at 14000 rpm for 15 
minutes at 4˚C. The supernatant was carefully discarded so as to retain the pellet and the 
pellet was washed with 1 ml of 70% ethanol by resuspending the pellet and 
centrifugation for 5 minutes at 14000 rpm. The pellet was finally obtained by discarding 
the 70% ethanol, air drying and resuspension in 50 µl of 1 X TE. 
 
 
3.1.4.5. Large-scale BAC plasmid isolation  
 
To obtain highly pure BAC plasmid for sequencing, restriction enzyme analysis and 
transformation a large scale preparation of BAC plasmids was carried out using 
Nucleobond PC Kits AX500. Briefly, 500 ml of a bacterial culture was spun down and 
resuspended in 24 ml solution S1. This was followed by lysis with 24 ml of solution S2 
and neutralization by 24 ml of solution S3. The cell debris was removed by filtering the 
bacterial lysate through filter paper, and the clear supernatant was transferred onto 
equilibrated silica columns optimised for plasmid DNA binding and washed with buffer 
N3. Bound plasmid DNA was eluted with prewarmed 14 ml of elution solution N5 and 
precipitated with l0.5 ml of isopropanol. The supernatant was carefully discarded so as 
to retain the pellet and the pellet was washed with 70% ethanol. The pellet was finally 
resuspended in Tris-EDTA pH 8.0. 
 
 
3.1.5. BAC plasmid mutagenesis  
 
The mutation of BAC plasmids was carried out either by ET cloning or shuttle 
mutagenesis. 
 
 
3.1.5.1. ET Cloning 
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The 40 bp mutant BAC plasmid was constructed by ET cloning (Fig 3.1) (Zhang et al. 
1998; Adler et al. 2000; 2003). This method uses the recombinant proteins recE and 
recT of E. coli strain JC8679 for carrying out the homologous recombination between 
the linear and circular DNA and is therefore called ET cloning. For carrying out ET 
cloning, a linear PCR product was generated using a primer pair that contained 24 
nucleotides for the amplification of a tetracycline resistance gene from vector pCP 16 
flanked by FRT (FLP recognition target sites) and an additional 50 nucleotides 
homologous to the sequences flanking the MHV-68 40 bp internal repeat corresponding 
to nucleotide positions 26778–28191 in the MHV genome. PCR products were purified 
by electrophoresis in a 1% low-melting-point agarose gel, extracted with phenol-
chloroform, and resuspended in 25 µl of Tris-EDTA pH 8.0 buffer. 10 µl of the linear, 
PCR-generated fragments were electroporated into E. coli JC8679 (recBC sbcA) 
containing the MHV-68 BAC plasmid. Bacteria were incubated at 37°C for 1 hour and 
plated onto agar plates containing chloramphenicol (17 µg/ml) and tetracycline (10 
µg/ml). Plasmid DNA was isolated and analyzed by restriction enzyme digestion and the 
correct 40 bp mutant BAC plasmid was identified and used further. To remove the 
tetracycline resistance gene from the 40 bp mutant BAC plasmid, the 40 bp BAC 
plasmid was retransformed into E. coli DH10B. The Flp expression plasmid pCP20 was 
electroporated into E. coli DH10B containing the 40 bp mutant BAC plasmid. The 
bacteria were plated onto chloramphenicol-ampicillin (100 µg/ml) LB agar plates and 
grown overnight at 30°C. Colonies were replated on chloramphenicol-containing plates 
and grown overnight at 43°C. Colonies were again replated on both chloramphenicol- 
and tetracycline-containing plates and grown overnight at 37°C. BAC plasmids from 
chloramphenicol-positive, tetracycline-negative colonies were analyzed by restriction 
enzyme analysis for the loss of the tetracycline resistance gene.  
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Fig 3.1. ET cloning for the mutagenesis of the BAC cloned MHV-68 genome in E. coli. The procedure 
can be performed in E. coli strains such as JC8679 which constitutively express rec E and rec T. A 
selectable marker gene (tetracycline gene   ), flanked by FRT sites (   Ab   ), is created by PCR 
using primers which contain homologies of about 50 nucleotides according to the desired integration site 
at their 5’-ends, the mutation and the priming regions specific for the selectable marker gene. The 
generated linear DNA fragment is transferred to the MHV-68 BAC by a double crossing-over event. The 
tetracycline cassette can be excised by recombinase FLP, leaving behind one FRT site. 
(modified from Adler et al. 2003) 
 
 
3.1.5.2. Two step replacement procedure (Shuttle mutagenesis) 
 
The 40 bp revertant BAC plasmid, M6 Stop mutant BAC plasmid, M6 Point mutant 
BAC plasmid and M6 Stop + Point mutant BAC plasmid were constructed by shuttle 
mutagenesis as described (Adler et al. 2000; 2003; Messerle et al. 1997) (Fig 3.2). For 
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carrying out the two step replacement procedure, first a DNA fragment of interest 
containing either a mutant or the wild type fragment (to generate a revertant virus) was 
cloned into the shuttle plasmid pST76K-SR which contains the recA gene. The recA 
protein facilitates homologous recombination leading to the formation of a cointegrate; 
i.e., BAC plasmid with shuttle plasmid sequences. The shuttle plasmid pST76K-SR was 
electroporated into E. coli DH10B bacteria that already contained either wild type 
MHV-68 BAC plasmid or mutant MHV-68 BAC plasmid. Transformants were selected 
at 30°C on LB agar plates containing chloramphenicol and kanamycin. Clones 
containing cointegrates were identified by streaking the bacteria onto new LB plates 
with chloramphenicol and kanamycin and incubating them at 43°C. To allow resolution 
of the cointegrates, clones were streaked onto LB plates containing chloramphenicol and 
incubated at 30°C. To select for clones that had resolved the cointegrate and that 
contained the mutant BAC plasmid, bacteria were restreaked onto LB plates containing 
chloramphenicol and 5% sucrose. Resolution of the cointegrate was confirmed by 
testing for the loss of the kanamycin resistance cassette encoded by the shuttle plasmid. 
BAC plasmid DNA was isolated from 10 ml overnight cultures by the alkaline lysis 
procedure and characterized by restriction enzyme analysis. 
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Fig 3.2. Two step replacement procedure (shuttle mutagenesis) for mutagenesis of the BAC cloned 
MHV-68 in E. coli. The mutant allele (Mut), flanked by the sequences homologous to the desired 
integration site, is provided by a shuttle plasmid with a temperature-sensitive replication mode and the 
negative selection marker SacB which allows bacteria harbouring a resolved cointegrate to be selected. 
The shuttle plasmid also contains a kanamycin resistance gene (not shown), while the BAC plasmid 
contains a chloramphenicol resistance gene (not shown). For mutagenesis in E. coli DH10B, the shuttle 
plasmid also provides the recA gene for homologous recombination. In the first step, the shuttle plasmid 
carrying the desired mutation plus flanking homologies (black boxes) is transformed into bacteria already 
containing the BAC plasmid. Through the homologous recombination via one of the two homologies, the 
shuttle plasmid is completely integrated into the viral BAC genome, leading to a cointegrate. Bacteria 
containing the cointegrate are selected by incubation at 43oC plus both antibiotics. Resolution of the 
cointegrate via one of the two homologies leads to either wild type (WT) or mutant (Mut) BAC plasmid. 
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Bacteria harbouring a resolved cointegrate are selected at 30oC on agar plates containing 5% sucrose 
(counter-selection against SacB) together with the antibiotic whose resistance gene is encoded on the 
BAC. 
(modified from Adler et al. 2003) 
 
 
3.2. Molecular biology techniques 
3.2.1. Strategies for cloning  
 
All the cloning work was performed according to the protocols described (Sambrook 
and Russell 2001). Plasmid DNA was digested as necessary with 1 or 2 restriction 
enzymes and purified by agarose gel electrophoresis. Depending upon the requirements, 
the linearised plasmid DNA or the insert DNA fragment were treated with either 
alkaline phosphatase to remove 5’-phosphate groups or DNA polymerase I Klenow to 
repair 3’ or 5’ overhanging ends to generate blunt ends. The linearised plasmid vector 
was ligated with the insert DNA fragment obtained either by PCR reaction or restriction 
enzyme reaction of plasmid DNA, in a volume of 15 μl. The molar ratio of vector to 
insert was 1:3. Ligation was performed at 16°C overnight in the presence of 40 U of T4 
DNA ligase. 50 μl of competent bacteria were transformed with the total ligation 
reaction. 
 
 
3.2.1.1. Generation of pUC 19 M6 Stop mutant 
 
Construction of the recombinant plasmid pUC 19 M6 Stop was completed by generating 
a 838 bp Xho I- Hind III fragment by PCR on pST76K-SR M6 using primers M6 Stop 
forward and reverse (see materials 2.7.2.). The M6 Stop reverse primer contains stop 
codons in all three frames thus adding stop codons to the 3’ end of the PCR product. 
Further, the addition of the stop codons generates a recognition site for the restriction 
enzyme Hpa I. The PCR product was digested with Xho I-Hind III and cloned into pUC 
19 using the Xho I-Hind III sites. The resulting plasmid was named pUC 19 M6 Stop.  
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3.2.1.2. Generation of pUC 19 M6 Point mutant 
 
The pUC 19 M6 Point mutant plasmid was generated by a 2 step PCR mutagenesis 
replacing the start codon of M6 (ATG) by ACG. For this purpose, in the first round 2 
PCR products were generated by PCRs on pST76K-SR M6, the first using primers (see 
materials 2.7.2) M6 Point forward I and M6 Point reverse 2 and the second using 
primers M6 Point forward 2 and M6 Point reverse 2. Using a mixture of these two PCR 
products as template and the primers M6 Point forward 1 and M6 Point reverse 2, an 
822 bp fragment was generated. Following digestion with Xho I and Hind III, this new 
PCR product was cloned into pUC 19 M6 using Xho I and Hind III. 
 
 
3.2.1.3. Generation of pUC 19 M6 Stop + Point mutant 
 
Although the ORF M6 Point mutant contains a point mutation in the start codon, the 
proposed ORF M6 sequence contains another ATG downstream at the 5’ end of the 
Hind III restriction site, where transcription could potentially start. Although, the 
downstream ATG is not in the same frame as ORF M6, it can regain the same frame as 
ORF M6 due to presence of 40 bp repeats. Thus, in order to make sure that all possible 
ORF M6 gene products are disrupted, we decided to construct a double mutant, 
essentially containing the mutation in the start codon as the Point mutant and also the 
features of the Stop mutant. For this purpose, a PCR was performed on pUC 19 M6 
Point mutant using primers used for construction of the pUC 19 M6 Stop plasmid. This 
PCR product containing the double mutation was cloned into the pUC 19 plasmid using 
Xho I and Hind III. The ligated product was named pUC 19 M6 Stop + Point mutant. 
 
 
3.2.1.4. Generation of pST76K-SR M6 mutants 
 
After pUC 19 M6 Stop, pUC 19 M6 Point mutant and pUC 19 M6 Stop + Point 
mutant were confirmed by sequencing and restriction enzyme analysis, a 5.237 or 5.253 
kbp Kpn I – Nde I fragment from pUC 19 M6 plasmids were cloned into pST76K-SR 
 44
                                                                                                                   Methods 
M6 using Kpn I and Nde I, and named according to the mutants of pUC19 M6, i.e., 
pST76K-SR M6 Stop, pST76K-SR M6 Point and pST76K-SR M6 Stop + Point.  
 
 
3.2.1.5. Generation of ORF M6 BAC mutants 
 
The BAC plasmid mutants were generated by a two-step replacement procedure as 
described in methods (3.1.5.2). For that purpose, the shuttle plasmid pST76K-SR 
containing the appropriate mutations in a 5.916 kbp fragment was electroporated into 
E. coli strain DH10B, which already contained the MHV-68 BAC plasmid. The 
homologous recombination between shuttle plasmid pST76K-SR M6 mutant and MHV-
68 BAC plasmid led to the formation of ORF M6 BAC plasmid mutants. They were 
named according to the mutation they were carrying, i.e., M6 Stop mutant, M6 Point 
mutant and M6 Stop + Point mutant.  
 
 
3.2.2. Circular viral DNA isolation 
 
Circular viral DNA was isolated from infected NIH 3T3 cells by the method described 
by Hirt (Hirt 1967; Messerle et al. 1997). Briefly, 2-10 x 107cells were trypsinized and 
harvested. After harvesting the cells, they were washed with phosphate-buffered saline 
and resuspended in 500 μl of Tris-EDTA (100 mM Tris-HCl, 20 mM EDTA, pH 8.0). 
Resuspended cells were treated with 500 μl of 1.2% sodium dodecyl sulphate. The 
cellular genomic DNA and proteins were precipitated by addition of 660 μl 5 M NaCl 
overnight at 4oC. Following the addition of NaCl, the samples were centrifuged at 14000 
rpm for 30 minutes. The solution free of cell debris was extracted and treated with an 
equal volume of phenol: chloroform: isoamylalcohol (25:24:1). The samples were 
mixed by inverting the tubes for 10 minutes and centrifuged at 14000 rpm for 10 
minutes at 4oC. After the centrifugation the aqueous phase was transferred to a fresh 
tube. The viral DNA was precipitated with an equal volume of absolute ethanol, washed 
with 70% ethanol, and finally resuspended in TE buffer (10 mM Tris-HCl-1 mM EDTA, 
pH 7.5). 
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3.2.3. RNA isolation  
 
After 24 hours of infection, total RNA from infected or uninfected cells (NIH 3T3 or 
Ag8) was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA). Briefly, 5-10 x 
106 cells were washed with PBS and 1 ml of TRIZOL was added to lyse the cells. 0.2 ml 
of chloroform was added to the cell lysate for dissociation of nucleoprotein complexes 
and after the centrifugation, the aqueous phase was transferred to a fresh tube. Total 
RNA was precipitated with 0.5 ml of isopropanol and the pellet was washed with 70% 
ethanol. The air dried RNA pellet was dissolved in 40-50 μl RNase-free water. 
 
 
3.2.4. Isolation of total DNA 
 
Genomic DNA from Ag8 cells or splenocytes was isolated using the QIAamp DNA 
Mini Kit (Qiagen). Briefly, 5 x 106 cells were spun down by centrifugation for 5 min at 
2500 rpm, and the pellet was resuspended in 200 μl of PBS. 20 μl of proteinase K 
(Qiagen) was added to the cells along with 200 μl of buffer AL to lyse and mix the cells 
by pulse vortexing for 15 seconds. After lysis of the cells, 200 μl of ethanol (100%) was 
added to the sample and mixed again by pulse vortexing for 15 seconds. The cell lysate 
was then loaded on the QIAamp spin column and washed with buffer AW1 and AW2. 
Finally, the genomic DNA was eluted with 200 μl of buffer AE.  
 
 
3.2.5. Reverse transcription PCR 
 
DNase treated RNA (2 μg) was reverse transcribed by using a 1st strand cDNA 
Synthesis Kit for RT-PCR (AMV)+ from Roche Diagnostics Corp. in 20 μl system. A 
reverse transcriptase control (without reverse transcriptase) was included in the 
experiments. The primer sequences for the ORF K3 gene were 5’-
GAGAGTTCTGTTGGATCTGC-3’ and 5’-GTCGCGATCGCCTCATCAATG-3’. The 
conditions for PCR were as follows: initial denaturation at 94oC for 3 min followed by 
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30 cycles of 94oC denaturation for 30 sec, 55oC annealing for 30 sec and 72oC synthesis 
for 30 sec. The products were analysed on 1% agarose gels. Also, the house keeping 
gene eF1β, GAPDH was amplified by PCR from the cDNA samples, to check the input 
of cDNA.  
 
 
3.2.6. Non-radioactive Southern blot analysis 
 
5-10 μg viral DNA were digested with restriction enzymes and separated on a 0.8% 
agarose gel in 1 X TBE buffer at 60-70 V overnight. DNA bands were visualised under 
UV light after staining with ethidium bromide (50 ng/ml in 1 X TBE). After 
visualisation, the agarose gel was submerged into depurination solution for 10-20 min, 
and subsequently into denaturation buffer for 30-60 min and finally to neutralisation 
buffer for 30-60 min with agitation. After setting up the capillary blot, the DNA was 
transferred onto a nylon membrane (Hybond N, Amersham) overnight in 20 X SSC. The 
DNA was cross-linked to the membrane by UV cross-linking at 1200 J and baking at 
80oC for 2 hours. After cross-linking, the membrane was soaked in 2 X SSC, and 
prehybridised with prehyb-mix for 2 hours at 68°C. For hybridisation, the DIG-labelled 
probe (10 ng/ml in prehyb-mix) added to freshly replaced prehyb-mix on the membrane 
and hybridisation was carried out at 68°C overnight. To prepare DIG-labelled probe, a 
PCR product (100 ng to 2 μg) was denatured and immediately cooled down on ice and 
finally labelled as per directions in DIG-labelling manual. After hybridisation, the 
membrane was washed 2 times for 5 min each in wash buffer I at room temperature. 
After the first round of washing, the membrane was washed again with wash buffer II 
twice 15 minutes each at 68°C. After this step, all the subsequent incubations and 
washing were done at room temperature. The membrane was incubated in 30 ml of DIG 
I solution for 5 min followed by incubation with DIG II solution for 30 min. 1 μl of α-
DIG-AP conjugate (Roche) was added to fresh DIG II solution and incubated on the 
membrane for 30 min. After washing 2 x 15 min in DIG I solution containing 0.3% 
Tween 20, the membrane was first equilibrated in DIG III and then incubated for 5min. 
Then, 1.5 ml of DIG III containing 15 μl of substrate solution (CDP-Star-ready-to-use 
substrate, Roche, Germany) was added onto the membrane and incubated for 5 minutes. 
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After the incubation, the membrane was exposed to X-ray film for 10 minutes to 2 hours 
depending upon the intensity of signal. 
 
Southern blot analysis for characterization of viral mutants  
The probe for southern blot analysis was prepared by PCR amplification with primers 
M6 point for1 5’-AAT ATA AAC TCG AGG CGG CAA GG-3’ and M6 Point rev2 5’ 
AAGCTCGTGAAAGCTTTTATATCAGAATAA-3’ using MHV-68 BAC plasmid as 
template. 
 
1 X TBE: 40 mM Tris-Cl (pH 8.0); 5 mM Na-acetate; 1mM 
EDTA 
Depurination solution: 0.25 N HCl 
Denaturation buffer: 0.75 M NaCl; 0.25 N NaOH 
Neutralisation buffer: 0.25 M Tris-Cl, pH 7.2; 0.75 M NaCl 
20xSSC: 3 M NaCl; 300 mM Na3- citrate. 2H2O, pH 7.0 
Prehyb-mix: 5% SSC; 1% blocking reagent, 0.02% SDS; 0.1% 
Lauroylsarcosin solution 
10xblocking reagent: 10% ( w/v) blocking powder (Roche, Germany); 100 
mM Tris/HCl pH 7.5; 150 mM NaCl 
Wash buffer 1: 2% SSC; 0.1% SDS 
Wash buffer 2: 0.1% SSC; 0.1% SDS 
DIG I: 100 mM Tris/HCl pH 7.5; 150 mM NaCl 
DIG II: 100 mM Tris/HCl pH 7.5; 150 mM NaCl; 1% 
Blocking reagent  
DIG III: 0.1 M Tris/HCl pH 9.5; 0.1 M NaCl 
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3.2.7. Real Time PCR 
 
To determine the genomic load of latent virus in splenocytes, real time PCR was 
performed. It is based on the measurement of the increasing incorporation of the 
fluorescent SYBR Green I dye into dsDNA. Real-time PCR was done in 20 µl volumes 
containing the following reagents: 12.6 µl water, 2.4 µl MgCl2, 1 µl of each primer (10 
mM), 2 µl of SYBR Green PCR Master Mix, and 2 µl of DNA template. The reaction 
mix was added to a capillary and sealed. The cycling parameters were hot start at 95oC 
for 10 minutes, denaturation at 94oC for 10 seconds, annealing at 60oC for 20 seconds 
and extension at 72oC for 30 seconds. Melting curve analysis was carried out to confirm 
the specificity of the products between 65-95oC with 0.2oC increments. The PCR 
products obtained from real time PCR were also analyzed by agarose gel 
electrophoresis. A portion (262 bases) of the MHV-68 ORF 50 gene was amplified with 
the forward primer 5`- CCCCAATGGTTCATAAGTGG -´3 and reverse primer 5’- 
ATCAGCACGCCATCAACATC -`3. The MHV-68 genome copy number was 
estimated against a standard curve constructed by serial dilution of plasmid pUC19 
ORF50 (Eco RI – Ava I fragment 65707-69550 nucleotide position of MHV-68). In each 
reaction, equal amounts of spectrophotometrically estimated DNA were added. The 
amount of DNA was also confirmed by the estimation of the murine ribosomal protein 
L8 (rpl8) gene (Genbank accession number AF091511) by real time PCR. The standard 
curve for rpl8 was constructed by serial dilution of a plasmid containing a 163 bp 
fragment of rpl8 (pCR2.1/rpl8). Amplification of pCR2.1/rpl8 was carried out using 
forward primer 5’-CAGTGAATATCGGCAATGTTTTG -`3 and reverse primer 5’-
TTCACTCGAGTCTTCTTGGTCTC -´3. Each sample was tested in triplicates. 
Real-time PCR were also used for quantification of mRNA in a sample. For this purpose 
cDNA from 2 μg RNA sample were prepared and expression of MK3 and murine 
ribosomal protein L8 (rpl8) were checked in similar condition as for estimation of 
genomic load with the specific primers for MK3 and L8 gene. 
 
Light Cycler master mix: 12.6 μl water; 2.54 μl MgCl2 (25 mM); 1 μl of each 
primer (10 mM); 2 μl Master SYBR Green  
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3.3. Eukaryotic cell culture and virological methods  
3.3.1. Cultivation of eukaryotic cells  
 
All the eukaryotic cells were grown at 37°C in a 5% CO2 humidified incubator. Cells in 
suspension were usually split every third day 1:10 with fresh medium. Living cells were 
distinguished from dead cells by tryphan-blue (0.4%) staining. Ag8 cells were 
maintained in RPMI 1640 medium (Invitrogen, Germany) supplemented with 10% 
newborn calf serum, penicillin (100 U/ml), streptomycin (100 µg/ml) and 2 mM L-
glutamine. The adherent fibroblast cells NIH 3T3 and 293 T cells were cultured in 
DMEM high glucose media (Invitrogen, Germany) with 10% newborn calf serum, 
penicillin (100 U/ml), streptomycin (100 µg/ml) and 2 mM L-glutamine. The fibroblast 
cells were split twice a week. Confluent cultures were washed with PBS and cells 
detached by addition of trypsin-EDTA solution (GIBCO). The BHK-21 cells were 
maintained in Glasgow’s modified Eagle's medium (GIBCO) supplemented with 5% 
newborn calf serum, 5% tryptose-phosphate broth, penicillin (100 U/ml), streptomycin 
(100 µg/ml) and 2 mM L-glutamine. 
 
 
3.3.2. Generation of recombinant viruses 
 
A total of 5 µg MHV-68 BAC plasmid was mixed with 10 μl of superfect reagent 
(Qiagen) and incubated at 37oC for 10 minutes, followed by addition of 1 ml DMEM 
medium. DMEM medium containing the superfect reagent and the BAC plasmid was 
added to NIH 3T3 cells, and the cells were incubated for 3-5 hours (Fig. 3.3).  
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Fig. 3.3. Generation of recombinant viruses. Recombinant viruses were prepared by transfection of 
BAC plasmids into eukaryotic cells. Propagation of the virus in fibroblasts expressing Cre recombinase 
results in deletion of DNA sequences of BAC vector. Viral clones with BAC sequences excised were 
cultured in fibroblast cells to prepare the virus stocks. 
(modified from Adler et al. 2000) 
 
 
After incubation, the medium was aspirated and fresh DMEM medium was added, and 
the cells were cultured for 3-4 days till 70-90% cytopathic effect was observed. The 
supernatant from these cells containing the virus was collected and stored at -80oC. To 
remove the BAC vector sequences, rat embryonic fibroblasts expressing Cre 
recombinase were infected with the virus harvested from NIH 3T3 cells. Viral clones 
with the BAC vector sequences excised were purified by limiting dilution using loss of 
GFP expression as a marker. DNA of the mutant, parental and revertant viruses was 
isolated from infected BHK-21 cells and analyzed by restriction enzyme digestion and 
southern blot analysis. 
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3.3.3. Preparation of virus stocks 
 
Virus stocks were prepared on BHK-21 cells. BHK-21 cells were seeded in 75 cm2 
flasks one day prior to the infection. Viral clones obtained from limiting dilution were 
used for infection of BHK-21 cells at an MOI of 0.1 in 5 ml of complete Glasgow’s 
modified Eagle's medium (GIBCO). Cells were incubated in virus containing media for 
one hour at 37oC. Excess virus in culture was removed by aspirating the media and 
supplementing the culture with fresh complete Glasgow’s modified Eagle's medium 
(GMEM)(GIBCO). The cells were cultured for 4-5 days till complete cytopathic effect 
was achieved. The cells were harvested by trypsinization and washed with Glasgow’s 
modified Eagle's medium (GIBCO). The cell pellets were resuspended in 1ml of fresh 
Glasgow’s modified Eagle's medium (GIBCO) media, and two rounds of freeze and 
thaw were performed to release intracellular virus. The cell debris was pelleted down 
and viruses in the supernatant were stored at -80oC. The virus titers for the stocks were 
determined by plaque assay. 
 
 
3.3.4. Plaque assay 
 
BHK-21 cells were seeded in 24 well plates one day prior to infection to give 60-70% 
confluence at the time of infection. The virus containing samples were 10-fold serially 
diluted in Glasgow’s modified Eagle's medium (GIBCO) media. The medium from the 
wells was aspirated, and 900 μl of each dilution was added on top of BHK-21 cells. 
After 90 minutes of incubation at 37°C, the virus suspension was aspirated and 2 ml of 
prewarmed overlay medium per well was added. The cells were then cultured for 4-5 
days at 37oC and 5% CO2. After the formation of plaques, the medium was aspirated 
and stained with 1 ml of crystal-violet solution for 10 minutes. After the staining, the 
cells were washed with water and plates were dried. The number of plaques per well 
were counted and the titer was calculated according the following formula:  
PFU/ml = 1/dilution X number of plaques X 1/(ml inoculum per well). 
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Overlay medium: Glasgow’s modified Eagle's medium (GIBCO) 
complete media with 0.75% carboxy 
methylcellulose; 32.7 mM NaHCO3
Crystal-violet stain: 0.1% Crystal-violet in 1% formaldehyde in PBS 
 
 
3.3.5. In vitro growth curves 
 
NIH 3T3 cells were plated at 0.3 x 106 cells per well in six well plates 1 day prior to 
infection. At the time of infection, NIH 3T3 cells were infected with 0.1 PFU per cell 
(multiplicity of infection = 0.1) of each virus in 1 ml volume with plates rocked every 
15 min for 1 h at 37°C. After this hour, virus containing media was aspirated and 2 ml 
of complete Dulbecco’s modified Eagle’s medium (DMEM) was added to the 
monolayer. This time was defined as time zero post infection. At the time of harvesting, 
cells and supernatant were harvested and stored at –80°C. The amount of infectious 
virus in culture was estimated by plaque assay on BHK-21 cells. Prior to the plaque 
assay, samples were subjected to two cycles of freeze and thaw. 
 
 
3.3.6. In vitro reactivation assay  
 
For the in vitro reactivation assay, naive mouse splenocytes from C57BL/6 mice were 
infected overnight with virus at an MOI of 1. The infected splenocytes were harvested 
and subjected to two washes with RPMI complete medium to get rid of remaining lytic 
virus present in the medium. Serial threefold dilution (8 dilutions) of single cell 
suspensions of spleen cells (starting with 10,000 splenocytes) were plated before or after 
mechanical disruption of viable cells (by two freeze-thaw cycles) on a monolayer of 104 
low-passage NIH 3T3 cells per well in 96-well tissue culture plates. Twenty four wells 
were plated per dilutions and NIH 3T3 cells were screened microscopically for viral 
cytopathic effect for up to 3 weeks. The mechanically disrupted cells allow 
quantification of preformed lytic virus.  
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3.3.7. FACS analysis 
 
Single cell suspensions of splenocytes were immunostained with various fluorescence-
conjugated antibodies. Staining was performed in FACS-buffer (PBS with 2% FCS) 
using 1 μg of antibody per 106 cells. Samples were incubated at 4oC for 30 minutes in 
the dark, washed with FACS-buffer, and resuspended in 0.5 ml of 2% PFA in PBS. 
Fluorescence was detected using a FACSCalibur flow cytometer and analyzed using the 
CellQuest software.  
 
 
3.4. Pathogenesis in mice 
 
The in vivo properties of all viruses were studied in female C57BL/6 mice, age 8 to 10 
weeks 
 
 
3.4.1. Maintenance of mice 
 
Mice were housed in individually ventilated cages (ivc) at the mouse facility of the Max 
von Pettenkofer-Institute, LMU Munich, Germany. Mice were fed with autoclaved 
chow and supplied with sterile drinking water. All animal experiments were approved 
by the appropriate local authorities. 
 
 
3.4.2. Infection of mice 
 
Mice were infected intranasally with a dose of 5 x 104 PFU of the indicated viral strain 
in 40 μl of phosphate-buffered saline. Prior to infection, mice were anesthetised using 
70 µl of ketamine/xylazine by i.p. injection. In experiments where CD8-/- or β2 
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microglobulin-/- mice were used, parental mice obtained from the same laboratory were 
used in parallel as controls. 
 
 
3.4.3. Determination of viral titers in the lungs of infected mice 
 
At days 3, 6, 10 and 13 post infections, mice were sacrificed and lungs harvested. 
Harvested lung tissue was stored in 1 ml of Glasgow’s modified Eagle’s media at -80°C 
for future use. Thawed lung tissue was homogenized by douncing and subjected to two 
rounds of freezing and thawing to disrupt the tissue structure. The resulting suspension 
was vortexed and used directly in plaque assays on BHK-21 cells to determine the viral 
titer as described above (3.3.4). To determine the limit of detection of the assay, known 
amounts of virus were added to uninfected lung tissue, homogenized, and after two 
rounds of freezing and thawing, the virus titers were estimated by plaque assay. It was 
found that 50 PFU was the limit of detection.  
 
 
3.4.4. Preparation of mouse splenocytes 
 
Spleens harvested from mice were immersed in 15 ml Falcon tubes in 3 ml complete 
DMEM. Single cell suspensions were obtained by macerating the spleens between the 
frosted surfaces of two glass slides. Single cell suspensions thus obtained were vortexed, 
centrifuged at 1200 rpm for 10 minutes at 4oC and the supernatant was discarded by 
inversion of the tube. The cells were resuspended in the residual supernatant. 5 ml of 
erythrocyte lysis buffer were added to the suspensions and incubated at room 
temperature for 5 minutes to lyse the erythrocytes. 8 ml of medium (DMEM) was then 
added to the cells to dilute the lysis buffer. Cell pellets were then obtained by 
centrifugation. Splenocytes were resuspended in 4-8 ml of fresh medium as necessary 
and used for further purposes. Where indicated, such single cell suspensions were frozen 
down at -80°C for future use. 
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Erythrocyte lysis buffer:     NH4Cl 0.15 M; KHCO3 1.0 mM; Na2EDTA 0.1 
mM; (pH 7.2-7.4)       
 
 
3.4.5. Ex-vivo reactivation assay  
 
To determine the load of preexisting lytic infectious virus and the extent of reactivation 
of latent virus in the splenocyte preparations from infected mice, an ex vivo limiting-
dilution reactivation assay was carried out. For this purpose, serial threefold dilution (8 
dilutions) of single cell suspensions of spleen cells were plated before or after 
mechanical disruption of viable cells (by two freeze-thaw cycles) on a monolayer of 104 
low-passage NIH 3T3 cells per well in 96-well tissue culture plates. Twenty-four wells 
were plated per dilution (starting with 1.5 x 105 splenocytes). The NIH 3T3 cells were 
screened microscopically for viral cytopathic effects for up to 3 weeks. At day 13, 17 
and 23 post infections, the splenocytes from wild type C57BL/6 mice carried only latent 
virus and no lytic virus was detected in the assay. However, in CD8-/- and β-2 
microglobulin knockout mice, the first dilution of single cell suspension of spleen cells 
showed the presence of a small amount of preformed lytic virus. 
 
 
3.5. Statistical analysis  
 
Data was evaluated by using the Student’s t test for dependent or independent samples 
(Microsoft EXCEL). Differences with P values < 0.05 were considered statistically 
significant. The data from the reactivation assays were statistically analyzed using the 
Graph Pad Prism software (GraphPad Software, San Diego, California). The frequency 
of reactivating splenocytes was calculated from the number at which 63% of the wells 
scored positive for reactivating virus based on the Poisson distribution, and then 
evaluated by using the t test. 
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4.0 Results 
4.1. Generation and characterization of the 40 bp internal repeat 
and/or ORF M6 mutants  
ORF M6 including the 40 bp internal repeats are located at the left side of the MHV-68 
genome (Fig. 4.1).  
 
40 bp internal repeats
ORF M6 
(nucleotide positions 26554-28308 bp)
100 bp internal repeat
TR TR
1 bp 119450 bp
 
Fig. 4.1. Schematic presentation of the MHV-68 genome. The MHV-68 genome consists of 
a 119450 bp unique DNA sequence which is flanked by multiple copies of terminal repeats (TR). The 
unique DNA sequence is also characterized by the presence of two internal DNA repeat sequences, i.e., 
the 40 bp internal repeat and the 100 bp internal repeat. The 40 bp internal repeat is located at the left side 
of the genome and is part of a hypothetical ORF M6. 
 
To determine the role of the 40 bp internal repeat and/or ORF M6, we constructed six 
independent viral mutants by different methods using MHV-68 cloned as a bacterial 
artificial chromosome (BAC). BACs allow the maintenance of large viral genomes as a 
plasmid in E. coli and the reconstitution of viral progeny by transfection of BAC 
plasmid DNA into eukaryotic cells. Many herpesvirus genomes have been successfully 
cloned as BAC including HCMV, MCMV, HSV, pseudorabies virus (PRV), EBV, 
HHV-8 and MHV-68 (Adler et al. 2000; Borst et al. 1999; Delecluse et al. 1998; 
Messerle et al. 1997; Saeki et al. 1998; Smith and Enquist 1999; Zhou et al. 2002). The 
low and stringently controlled copy number of BAC has made them superior to cosmids 
and yeast artificial chromosomes (Kim et al. 1992; Messerle et al. 1997; Shizuya et al. 
1992). Maintenance and manipulation of large viral genomes in E. coli is especially 
interesting for those viruses that are difficult to grow in cell culture systems and that are 
cumbersome to manipulate and to analyze. BACs provide an efficient, fast and valuable 
tool for mutagenesis using the bacterial recombination machinery. Construction of the 
mutant genome is completely independent of the biological fitness of the mutant virus, 
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and the recombinant genome can be characterized and controlled prior to reconstitution 
of viral progeny. MHV-68 cloned as BAC has the genes for gpt (guanosine 
phosphoribosyl transferase) and gfp (green fluorescent protein) as selection and 
screening markers and the chloramphenicol resistance gene for maintenance of BAC 
plasmids in E. coli (Adler et al. 2000) 
A schematic presentation of all the mutants is depicted in figure (4.2). In three of six 
mutants, the 40 bp repeat was either completely or partially deleted. In three further 
mutants, the N-terminus of ORF M6 was targeted leaving the repeat intact, except the 
loss of some of the repeat units during shuttle mutagenesis (see below).  
 
(Point mutation in the start codon)
(Insertion of a Stop codon in all three
frames at Hind III site and Point 
mutaton in the start codon )
ATG
Hind III
ATG
Hind III
Hind III
ACG
Stop
ATG
Hind III
ATG
ATG
Hind III
ATG
Stop
A G
1.  Wild Type/
Parental Virus
2.  40 bp mutant virus
3.  40 bp revertant virus
4.  40 bp moderate
mutant virus
5.  40 bp low mutant virus
6.  M6 Stop mutant virus
(BAC-derived virus)
(All repeats are deleted)
(Revertant of 40 bp 
mutant)
(Less than half of the
repeats are lost )
(More than half of the
repeats are lost )
(Insertion of a Stop linker at 
Hind III site )
Hind III
ORF M6
C
Point
Point
8.  M6 Stop + Point
mutant virus
7.  M6 Point mutant virus
 
Fig. 4.2. Schematic presentation of the generated mutants. The hypothetical ORF M6 as proposed by 
Virgin et al. 1997 is approximately 1.8 kb long and is located at the left side of the genome (nucleotide 
positions 26554-28308) (Virgin et al. 1997). Approximately 36 copies of the 40 bp direct repeats are 
present in ORF M6. The 40 bp mutant virus was made by ET cloning and all the other mutants as well as 
the revertant were generated by the two step replacement procedure. 
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4.1.1. Construction of the 40 bp mutant virus 
 
A deletion mutant (40 bp mutant), completely lacking the 40 bp internal repeat of MHV-
68, was constructed by ET cloning as described in methods (3.1.5.1). This method is 
called ET cloning since it utilizes the recombinant proteins recE and recT of E. coli 
strain JC8679. For this purpose, a linear PCR product was generated using the primers 
containing 24 nucleotides for the amplification of a tetracycline resistance gene flanked 
by FRT (FLP recognition target) sites and an additional 50 nucleotides homologous to 
the sequences flanking the MHV-68 40 bp internal repeat. Fragment was created by 
PCR from the plasmid pCP16. The PCR-generated fragments were electroporated into 
E. coli JC8679 (recBC sbcA) containing the MHV-68 BAC plasmid. Homologous 
recombination resulted in the generation of a BAC mutant completely lacking the 40 bp 
repeats. Thus, in the new BAC plasmid, the 40 bp repeat region was replaced by a 
tetracycline resistance cassette. The cloning of mutants was confirmed by restriction 
enzyme analysis and Southern blot analysis. The 40 bp mutant BAC plasmid was then 
transformed into E. coli DH10B containing the Flp expression plasmid pCP20. 
Chloramphenicol-positive, tetracycline-negative clones were then selected. After 
removal of the tetracycline resistance gene by FLP-mediated recombination, a small 
residual insert consisting of the FRT site and some vector sequence (161 bp) with an 
Eco RI restriction site was left in the disrupted 40 bp repeat sequence. This was 
confirmed by restriction fragment analysis with different enzymes and by sequencing. 
The 40 bp mutant virus was transfected into NIH 3T3 cells and virus reconstituted in 
baby hamster kidney (BHK-21) cells as described (3.2.2) and viral DNA from Hirt 
extracts of cells infected with recombinant virus was analyzed by restriction enzyme 
analysis and Southern blot analysis (Fig. 4.3 and 4).  
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5. 40 bp low mutant virus 
 
6. M6 Point mutant virus 
 
7. M6 Stop mutant virus 
 
8. M6 Stop + Point mutant 
virus 
Fig. 4.3. Construction of mutants and structural analysis of the genomes of reconstituted viruses 
Southern blot analysis of viral DNA isolated from the infected NIH 3T3 cells by the method of Hirt (Hirt 
1967) and digested with EcoR I. Viral DNA was hybridized with a 822 bp DNA probe (nucleotide 
positions 25889-26711). The 822 bp probe used for the Southern blot analysis binds at N-terminal region 
of ORF M6 and 670 bp DNA sequence present upstream of the 5’ end of ORF M6 (Fig. 4.4). 
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Fig. 4.4. Schematic presentation of the EcoR I fragment containing ORF M6 and the 40 bp repeat 
region of MHV-68. Digestion of MHV-68 genomic DNA with EcoR I generates 14 fragments of different 
lengths. The ORF M6 and/or 40 bp repeat region fragment of parental virus is 5.1 kbp long. Due to loss of 
repeats and insertion of a FRT site which also contains an EcoR I site, the 40 bp mutant fragment is 2.8 
kbp. The other mutants show different lengths of this fragment due to the loss of repeats. 
 
 
4.1.2. Construction of the 40 bp revertant virus 
 
The 40 bp mutant virus contains a deletion of ~ 1.2 kbp (nucleotide positions 26778–
28191). To ensure that the phenotype of the mutant virus is not due to rearrangements 
and/or mutations outside the mutated region, a revertant virus was generated by 
replacing the 40 bp mutant fragment with a wild type genomic fragment (nucleotide 
positions 24918-30834) by a two step replacement procedure. 
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For this purpose, a 5.916 kbp Sma I fragment of MHV-68 (nucleotide positions 24918-
30834) containing the 40 bp internal repeat region was cloned into the shuttle plasmid 
pST76K-SR, resulting in the plasmid pST76K-SR M6. This new plasmid pST76K-SR 
M6 was electroporated into E.coli DH10B containing the 40 bp BAC mutant plasmid. 
Homologous recombination between the shuttle plasmid pST76K-SR M6 and the 40 bp 
mutant BAC plasmid in the bacteria led to the formation of the revertant 40 bp BAC 
plasmid, which contains nearly all the repeats as well as an intact ORF M6 (Fig. 4.5.). It 
was not possible to restore the repeats completely, since few repeat units are always lost 
during the cloning and mutagenesis procedures. This has been described before by 
others (Virgin et al. 1997; Adler et al. 2000; 2003).  
 
Sma I Sma I
40 bp mutant BAC plasmid
ORF M6 
region
40 bp revertant BAC plasmid
ORF M6 
region
pST76K-SR M6
 
 
Fig. 4.5. The 40 bp revertant BAC plasmid prepared by homologous recombination between 
pST76K-SR M6 and the 40 bp mutant BAC plasmid. 
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Bacterial clones positive for the revertant 40 bp BAC plasmid were analyzed and 
confirmed by restriction enzyme analysis. Using a positive bacterial clone, the 
recombinant 40 bp revertant virus was reconstituted as before. 
 
 
4.1.3. Construction of the 40 bp moderate mutant and the 40 bp low 
mutant  
 
Restriction enzyme digestions and sequencing analyses showed that during shuttle 
mutagenesis, many clones lost a number of their 40 bp internal repeat units, due to 
recombination between the direct repeats. Two clones, i.e., the 40 bp low mutant which 
had lost more than half of the 40 bp repeat units, and the 40 bp moderate mutant which 
had lost less than half of the repeat units, were selected for further use. These two clones 
were used for the generation of mutant viruses lacking different numbers of 40 bp repeat 
units. They should allow determining the significance of the number of repeat units for 
in vitro replication and/or pathogenesis. Sequencing analysis showed that the 40 bp low 
mutant contained 15 repeat units. Probably due to the formation of secondary structures 
in the 40 bp moderate mutant, sequencing of the 40 bp moderate mutant was not 
possible. Restriction enzyme analysis of the 40 bp moderate mutant showed the loss of a 
considerable number of 40 bp repeat units, with approximately 20-25 copies of 40 bp 
repeat units left.  
 
 
4.1.4. Construction of the ORF M6 mutants  
 
Three additional mutants, i.e., ORF M6 Stop, ORF M6 Stop + Point, and ORF M6 
Point, were generated by targeting the N-terminus of ORF M6 using a two-step 
replacement procedure. For this purpose, a 5.237 kbp Kpn I – Nde I M6 fragment from 
pSTK-SR M6 plasmid was cloned into pUC 19 (Fig. 4.6). Prior to the cloning of the 
5.237 kbp fragment in pUC 19, the Hind III site from the multiple cloning site was 
disrupted. This construct pUC 19 M6 was used for PCR mutagenesis to generate the 
ORF M6 mutants. After PCR mutagenesis, the 5.237 kbp Kpn I – Nde I fragment was 
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cloned back into pST76K-SR M6 to generate pS76TK-SR M6 mutants. The mutant 
pST76K-SR M6 plasmids then underwent homologous recombination with MHV-68 
BAC plasmids generating ORF M6 mutant BAC plasmids. These ORF M6 BAC 
plasmid mutants were named according to the mutation they carried, i.e., M6 Stop 
mutant, M6 Point mutant and M6 Stop + Point mutant. Recombinant mutant viruses 
could be successfully reconstituted.  
 
        
pST76K-SR M6
Sma ISma I
MHV-68 BAC Plasmid
Sma I Sma I
Kpn I NdeI
NdeIKpn I
pUC 19 M6
pUC 19 M6 mutant
pST76K-SR M6 
mutant
Shuttle 
mutagenesis
NdeIKpn I
Cloning of Kpn I- Nde I fragment in pST
76K-SR-M6 plasmidCloning of Kpn I- Nde I fragment in pUC-19
Mutagenesis
By PCR
Mutation
 
Fig. 4.6. Schematic presentation of construction of ORF M6 mutants. For the construction of ORF M6 
BAC mutants, a 5.916 kbp Sma I fragment of MHV-68 (nucleotide positions 24918 to 30834) was cloned 
into the shuttle plasmid pST76K-SR. From pST76K-SR M6, a 5.237 kbp Kpn I – Nde I fragment was 
cloned into pUC 19, which was used for PCR mutagenesis to generate ORF M6 mutants. After the 
mutation in pUC 19 M6 plasmid, the 5.237 kbp Kpn I – Nde I fragment was cloned back into pST76K-SR 
M6 to generate the pSTK-SR M6 mutant. These pST76K-SR M6 mutant plasmids were used to generate 
ORF M6 BAC mutants by shuttle mutagenesis. 
 
The circular viral DNA from Hirt extracts of cells infected with recombinant virus was 
analyzed by restriction enzyme analysis and southern blot analysis. It was observed that 
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the ORF M6 mutant viruses, i.e., M6 Stop mutant virus, M6 Point mutant virus, and M6 
Stop + Point mutant virus had lost a considerable number of repeat units (as determined 
by restriction enzyme analysis), comparable to the 40 bp low mutant (Fig. 4.3 and 4). 
Therefore, in further studies, we compared the ORF M6 mutant viruses with the 40 bp 
low mutant virus and not with the parental virus. 
 
Summary of chapter 4.1 
1) All the mutant BAC plasmids for either the 40 bp repeat region or ORF M6 and the 
40 bp revertant BAC plasmid were constructed successfully by either ET cloning or 
shuttle mutagenesis. 
2) Recombinant viruses were reconstituted by transfection of all the BAC plasmids for 
either the 40 bp repeat region or ORF M6 and the 40 bp revertant BAC plasmid in 
fibroblasts. 
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4.2. The 40 bp internal repeat and/or ORF M6 of MHV-68 are 
dispensable for in vitro replication. 
 
Transfection of baby hamster kidney cells (BHK-21) with DNA of the parental virus or 
the BAC mutant for the 40 bp repeat or ORF M6 resulted in the reconstitution of 
infectious virus, indicating that the 40 bp internal repeat and/or ORF M6 are not 
essential for lytic replication. To check if the 40 bp internal repeat and/or ORF M6 have 
a role in in vitro replication, multi-step growth curve experiments were performed in 
NIH 3T3 cells (Fig. 4.7). NIH 3T3 cells, a mouse fibroblast cell line, efficiently support 
the lytic replication of MHV-68. 
 
Freeze and thaw 2 times
1:10 serial dilution
Titer estimation
by plaque assay
Samples  stored at -80 0C
Infection of  NIH 3T3  cells (0.3 x 106 cells
per well) at M.O.I of 0.1 in 6 well plate
Cells and supernantant were harvested
at different time intervals after infection
 
Fig. 4.7. Schematic presentation of in vitro multi-step growth curve. NIH 3T3 cells were infected with 
0.1 PFU per cell in 1 ml volume for one hour. The medium containing virus was aspirated, and 2 ml of 
fresh media were added.  At definite time intervals (i.e., 24, 48, 72 and 96 hours post infection), cells and 
supernatant were harvested and two rounds of freezing and thawing were performed. The virus titer was 
determined by plaque assay on BHK-21 cells.  
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For this purpose, NIH 3T3 cells were infected with different mutant viruses as well as 
parental virus at a M.O.I of 0.1 to determine the replication efficiency of all the mutant 
viruses compared to the parental virus. At definite time intervals (24, 48, 72 and 96 
hours post infection) the complete cultures (containing intracellular as well as 
extracellular virus) were harvested and viral titers were determined on BHK-21 cells by 
plaque assay.  
All mutant viruses, i.e., 40 bp moderate mutant virus, 40 bp low mutant virus, M6 stop 
mutant virus, M6 Stop + Point mutant virus, M6 Point mutant virus and 40 bp mutant 
virus replicated efficiently with similar kinetics and attained similar titers as both the 
parental virus and the 40 bp revertant virus (Fig. 4.8). At 24 and 48 hours post infection, 
the 40 bp mutant virus replicated less efficiently and the virus titers were 10 to 5 fold 
less than the parental virus. However, at 72 and 96 hours post infection, the 40 bp 
mutant virus attained similar titers as the parental virus. It was also observed that 
infection of NIH 3T3 cells or BHK cells with the parental virus or the mutant viruses 
either for the 40 bp internal repeat or ORF M6 resulted in the formation of plaques of 
similar size (data not shown). Thus, it can be concluded that the 40 bp internal repeats of 
MHV-68 and/or ORF M6 are dispensable for lytic replication in vitro. 
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Fig. 4.8. In vitro multi-step growth curves comparing the replication of mutant viruses of either the 
40 bp internal repeat or ORF M6 to the parental virus in NIH3T3 cells. Data shown are from 
representative, independent experiments. All together, 2-3 independent in vitro growth curves were 
performed with each mutant virus and compared to either parental or revertant virus. 
 
Summary for chapter 4.2 
The 40 bp internal repeat and/or ORF M6 of MHV-68 are dispensable for in vitro lytic 
replication. 
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4.3. The 40 bp internal repeats and/or ORF M6 of MHV-68 are 
dispensable for in vivo lytic replication 
 
To check the efficiency of acute lytic replication of the mutant viruses in vivo, C57BL/6 
mice were infected intranasally with 5 x 104 PFU of virus. Lungs of the mice were 
harvested at 3, 6, 10 and 13 days post infection and viral titers were determined on 
BHK-21 cells by plaque assay (Fig. 4.9).  
 
Lung samples were resuspended in 1 ml of GMEM 
medium and homogenized by douncing
2 rounds of freezing and thawing
1:10 Serial dilution
Titer estimation by
plaque assay
Lung samples were stored at -80 0C
Lungs of infected mice were harvested at 
different time  intervals
 
Fig. 4.9. Experimental design to monitor lytic replication in the lung of infected mice. The details are 
mentioned in methods (3.4.3.) 
 
The 40 bp mutant efficiently replicated in vivo and attained similar titers compared to 
parental MHV-68 at day 3 and 6 post infection (day 3: P = 0.1 and day 6: P = 0.996). 
Both viruses were cleared from the lungs at day 10-12 post infection (Fig. 4.10).  
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Fig. 4.10. The 40 bp internal repeat and/or ORF M6 of MHV-68 are dispensable for lytic replication 
in the lungs: C57BL/6 mice were infected with 5 x 104 PFU intranasally. At different days (day 3, 6, 10 
and 13), lungs were harvested and the virus titers from lung homogenates were determined by plaque 
assay on BHK-21 cells. Each symbol represents a single mouse. The limit of detection is 50 PFU and was 
determined by spiking uninfected lung tissue with known amount of virus (see 5.4.3.). For each group of 
mice the median value is indicated by a horizontal bar (-) and the P-values were determined by Student’s 
t-test. 
 
At day 6 post infection, all the other mutant viruses efficiently replicated in the lungs of 
C57BL/6 mice and their titers were not significantly different from the titers of the 
parental virus, i.e., M6 Stop + Point mutant virus (P = 0.59), M6 Point mutant virus (P = 
0.53), M6 Stop mutant virus (P = 0.63), 40 bp moderate mutant virus (P = 0.62). Thus, 
these data suggest that the 40 bp internal repeat of MHV-68 and/or ORF M6 are 
dispensable for acute, lytic replication in the lungs. 
 
Summary for chapter 4.3 
ORF M6 and/or 40 bp internal repeat of MHV-68 are dispensable for lytic replication 
in lungs. 
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4.4. The role of the 40 bp internal repeat of MHV-68 during the 
latent phase of infection in mice 
 
The role of the 40 bp internal repeat of MHV-68 in latency was investigated by 
measuring the extent of splenomegaly, ex vivo reactivation and genomic load of latent 
virus in the spleen. For this purpose, C57BL/6 mice were infected with 5 x 104 PFU of 
virus and the spleen was harvested at specific days post infection.  
 
 
4.4.1. The 40 bp internal repeat of MHV-68 is important for the virus-
induced transient splenomegaly 
 
The extent of splenomegaly was determined by measuring the spleen weight. At day 10, 
when establishment of latency starts after intranasal infection, the spleen weight of 
C57BL/6 mice infected with the 40 bp mutant was not significantly different to the 
spleen weight of mice infected with the parental virus (P = 0.623) (Fig. 4.11). However, 
during amplification of the latency stage, when massive proliferation of splenocytes 
takes place (splenic mononucleosis), i.e., day 13 and 17 post infection, the spleen weight 
of mice infected with the 40 bp mutant virus was significantly lower than the spleen 
weight of mice infected with the parental virus (day 13: P = 0.04 and day 17 P = 8 x 10-
7) or the revertant virus. At day 13 and 17 post infection, the weight of the spleen from 
mice infected with the 40 bp mutant virus was approximately 2 fold lower compared to 
the spleen weight of mice infected with parental virus. At days 23 and 42 post infection, 
when splenic mononucleosis decreases to a baseline, the extent of splenomegaly for the 
40 bp mutant virus and the parental virus was not significantly different (day 23: P = 
0.52 and day 42: P = 0.37). This data suggests that the 40 bp internal repeat and/or ORF 
M6 might have a role in latency and in the EBV-like infectious mononucleosis 
syndrome seen in mice after MHV-68 infection. 
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Fig. 4.11. The 40 bp internal repeat of MHV-68 is important for virus-induced splenomegaly. 
C57BL/6 mice were infected with 5 x 104 PFU intranasally. The extent of splenomegaly was measured by 
taking the spleen weight (mean values ± SD) of each mouse at different post infection days (day 10, 13, 
17, 23 and 42). Numbers in brackets represent the number of mice per group.  The asterisk indicates a 
significant decrease in the spleen weight of C57BL/6 mice infected with the 40 bp mutant virus compared 
to the infection with the parental virus (Student’s t-test).  
 
 
4.4.2. The 40 bp internal repeat of MHV-68 is important for viral 
reactivation from latently infected splenocytes 
 
To determine the level of viral reactivation from latently infected splenocytes at specific 
days after infection (day 10, 13, 17, 23 and 42), an ex vivo limiting dilution reactivation 
assay was carried out (Fig. 4.12). The limiting dilution reactivation assay provides an 
assay for simultaneously quantifying both preformed infectious virus and cells that 
reactivate latent MHV-68 (Weck et al. 1996, 1999 a & b). In this assay, latent cells are 
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serially diluted onto permissive monolayers and the presence of infectious virus is 
detected by cytopathic effect over 2-4 weeks in culture, allowing prolonged time for 
reactivation. To distinguish preformed infectious virus from latent virus, cells are 
mechanically destroyed (latent virus cannot reactivate from killed cells) and diluted in 
parallel with live cells (i.e. not mechanically destroyed) onto permissive monolayer. 
 
   
Splenocytes
96 well plate with constant 
number of fibroblasts and 
variable number of splenocytes
Mechanically disrupted Splenocytes Intact Splenocytes
Co-culture for 3 weeks
Check for cytopathic
effect caused  by
preformed lytic virus
Co-culture for 3 weeks
Check for cytopathic effect 
caused by reactivating latent 
virus
Spleen
Calculation of the frequency 
of ex vivo reactivating 
splenocytes
 
Fig. 4.12. Ex vivo reactivation assay for splenocytes: The details for the ex vivo reactivation assay are 
mentioned in methods (3.4.5.).  
 
At day 10 post infection, latent virus in the splenocytes of mice infected with the 40 bp 
mutant virus showed a similar extent of reactivation when compared to splenocytes from 
mice infected with parental virus (P = 0.47), i.e., the number of latently infected 
splenocytes which reactivated and entered the lytic phase of replication was similar (Fig. 
4.13). However, during the stage of amplification of latency (day 13 and 17 post 
infection), there was a significant decrease in the number of latently infected 
splenocytes which reactivated from mice infected with the 40 bp mutant virus (day 13: P 
= 0.05 and day 17: P = 0.025) (Fig 4.13.). At day 23 post infection, the extent of 
reactivation was again similar for both viruses (P = 0.99).  
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Fig. 4.13. The extent of ex vivo reactivation after infection of mice with the 40 bp mutant virus 
compared to the parental virus. Splenocytes from mice infected with either the 40 bp mutant virus or 
parental virus were used for the ex vivo reactivation assay at day 10 (a), 13 (b), 17(c) and 23(d) post 
infection. Splenocytes from 3 mice per group were pooled and serial dilutions were made, which were co-
cultured with NIH 3T3 cells for up to three weeks and checked for cytopathic effects in each well. For 
each dilution, cytopathic effect was monitored in 24 wells. Data shown are from single experiments at 
each time point, using pooled cells from 3 mice per group. The experiment at day 17 was repeated 3 times 
with similar results. 
 
The frequency of ex vivo reactivating splenocytes was determined by using the Poisson 
distribution, assuming that the cell number at which 63.2% of the wells scored positive 
for reactivation represents a single event. The frequencies of ex vivo reactivating 
splenocytes are represented as the reciprocal frequency of ex vivo reactivating 
splenocytes. For example, 1000 means 1 latently infected splenocyte is reactivating 
from 1000 splenocytes. The reciprocal frequency of reactivating splenocytes from 
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C57BL/6 mice was 2-2.5 fold less for the 40 bp mutant virus (1 in 15135) when 
compared to the parental virus (1 in 6875) at day 17 post infection (P = 0.04) (Fig. 
4.14).  
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Fig. 4.14. Reciprocal frequency of ex vivo reactivating splenocytes at day 17 post infection. To 
calculate the frequency of cells reactivating in the ex vivo reactivation assay, data were subjected to 
nonlinear regression to generate a curve fit based on a sigmoidal dose response curve. Frequencies of 
reactivation events were determined by using the Poisson distribution, assuming that the cell number at 
which 63.2% of the wells scored positive for reactivation represents a single event.  The asterisk 
indicates a statistically significant decrease in the reciprocal frequency of ex vivo reactivating splenocytes 
after the infection of mice with the 40 bp mutant virus compared to the infection with parental virus (P = 
0.04) (Student’s t-test). Data (mean values ± SD) are compiled from four independent experiments. 
 
 
4.4.3. The viral genomic load in the spleen of mice infected with the 40 
bp mutant is similar to the genomic load after infection with parental 
virus 
 
A significant decrease in spleen weight (day 17 P = 8 x 10-7) and a reduction in the 
extent of reactivation of latently infected splenocytes (2-2.5 fold) were observed in 
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C57BL/6 mice after infection with the 40 bp mutant virus as compared to infection with 
the parental virus. The difference in the extent of reactivation might be due to either a 
defect in the reactivation process per se or to a decrease in the genomic load of the 40 bp 
mutant virus in the spleen. To test whether the phenotype is a result of a decrease in the 
latent viral genome load per spleen and not to a defect in the reactivation process, real 
time PCR was performed. DNA was extracted from splenocytes of mice 17 and 42 days 
after infection with parental virus or the 40 bp mutant. 
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Fig. 4.15. The latent viral genome load in the splenocytes from mice infected with either the 
parental virus or the 40 bp mutant virus was not significantly different. C57BL/6 mice were infected 
with 5 x 104 PFU, and total DNA was extracted from splenocytes harvested at day 17 and 42 post 
infection. Real time PCR was performed with 100 ng of total splenocyte DNA using primers specific for 
the MHV-68 ORF 50 gene, to estimate the latent viral genome load in the spleen. Numbers in brackets 
represent the number of mice. Data (mean values ± SD) are compiled from two independent experiments.  
 
At day 17 as well as at day 42 post infection, the latent viral copy number per 100 ng of 
splenic DNA from mice infected with the mutant did not significantly differ from the 
copy number of the parental virus (Fig. 4.15). At day 42 post infection, the viral genome 
load was around 10 fold lower than that at 17 days post infection in both infection 
groups. 
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Summary for chapter 4.4 
1) The 40 bp internal repeat of MHV-68 is important for the amplification of latently 
infected cells. 
2) At day 17 post infection, the extent of reactivation for the 40 bp mutant virus was 2-
2.5 fold less than for the parental virus. 
3) At day 17 and 42 post infection, the latent viral copy number per 100 ng of splenic 
DNA from mice infected with either the 40 bp mutant virus or the parental virus was 
not significantly different. 
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4.5. The 40 bp internal repeat of MHV-68 is not important for in 
vitro reactivation 
 
During the amplification stage of latency, splenocytes from mice infected with the 40 bp 
mutant virus show a decrease in the extent of reactivation compared to splenocytes from 
mice infected with parental virus. However, the viral genome load in the splenocytes did 
not significantly differ. Therefore, we checked whether the reduction in the extent of 
reactivation was due to a defect in the reactivation process per se by performing an in 
vitro reactivation assay. The in vitro reactivation assay was carried out as described in 
methods (3.2.6). The in vitro reactivation assay was similar to the ex vivo reactivation 
assay except for the source of latently infected cells. In case of ex vivo reactivation assay 
the splenocytes were derived from infected mice and in in vitro reactivation assay the 
splenocytes were derived from a naïve mouse. Naive mouse splenocytes were infected 
with virus at an M.O.I of 1.0 overnight and serial three-fold dilutions of viable 
splenocytes (starting with 10,000 splenocytes) were plated on monolayers of 104 low-
passage NIH 3T3 cells per well in 96-well tissue culture plates and the frequency of 
reactivating cells was calculated from Poisson distribution.  
The 40 bp mutant virus established latency in the splenocytes and reactivated from the 
latently infected splenocytes to the same extent as did the parental virus (P = 0.98) (Fig 
4.16). In case of the 40 bp mutant virus, 1 in 48 splenocytes reactivated, and 1 in 57 in 
case of the parental virus. Also, the 40 bp revertant virus reactivated to a similar extent 
(1 in 61 splenocytes). Latent and persistent productive infection can coexist in the same 
culture. Therefore, we checked for the presence of preformed lytic viruses by co-
culturing the fibroblast cells with infected splenocytes which had been disrupted by two 
rounds of freezing and thawing. Only the first dilutions of splenocytes showed the 
presence of few lytic viruses. This data suggests that the 40 bp internal repeat of MHV-
68 might have no role in the reactivation process per se. The difference in the results of 
the ex vivo reactivation assay and the in vitro reactivation assay might be due to the 
difference in the source of splenocytes. The host immune response and several other in 
vivo factors could affect the ex vivo reactivation (Weck, Barkon et al. 1996; Weck, Kim 
et al. 1999), whereas in the in vitro reactivation assay, no host immune response is 
involved.  
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Fig. 4.16. The in vitro reactivation of the 40 bp mutant virus and the parental virus is not 
significantly different. Splenocytes from naïve mice were infected with different viruses at an M.O.I of 1 
overnight. The splenocytes were washed 2 times with DMEM and then three-fold dilutions of splenocytes 
were co-cultured with NIH3T3 cells for three weeks (closed symbols). Additionally, splenocytes disrupted 
by 2 rounds of freezing and thawing (F+T) were co-cultured for three weeks (open symbols) to detect the 
presence of preformed lytic viruses. The frequencies of cells reactivating in the in vitro reactivation assay 
were calculated as described in (4.4.2). 
 
Summary for chapter 4.5 
The 40 bp repeat of MHV-68 seems to have no role in the reactivation process per se.  
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4.6. Splenomegaly and the extent of reactivation of latently 
infected splenocytes are independent of a putative ORF M6 
protein expression 
 
4.6.1. The extent of splenomegaly depends on the number of 40 bp 
internal repeat units present in the MHV-68 genome but is 
independent of ORF M6 protein expression 
 
To determine whether ORF M6 protein expression is necessary for the EBV-like 
infectious mononucleosis syndrome in mice and/or viral reactivation from latently 
infected splenocytes, C57BL/6 mice were intranasally infected with 5 x 104 PFU of two 
selected ORF M6 mutant viruses, mutant viruses for 40 bp internal repeat and parental 
virus. Spleens were harvested at day 17 post infection. The spleen weights were 
determined and found to be highest in mice infected with parental virus, followed by the 
40 bp moderate mutant, the 40 bp low mutant and finally the 40 bp mutant virus (Fig 
4.17). Consistent with our previous results, the decrease in spleen weight of mice 
infected with the 40 bp mutant was significant (P = 0.0001), when compared to the 
spleen weight of mice infected with the parental virus. The decrease in spleen weight 
after infection with the 40 bp low mutant was still significant (P = 0.011), when 
compared to the spleen weight of mice infected with the parental virus, whereas the 40 
bp moderate mutant showed no significant decrease (P = 0.51). This suggests that the 
number of 40 bp repeat units determines the extent of splenomegaly. 
If the phenotype observed after infection with the 40 bp mutant would be due to 
disruption of ORF M6, then mutations in the N-terminus of ORF M6 (which prevent the 
expression of the putative M6 protein) should display the same phenotype. However, 
after infection with the ORF M6 mutant viruses, no significant difference in the spleen 
weight, when compared to the parental virus, was observed (M6 Stop mutant virus: P = 
0.105 and M6 Stop + Point mutant virus: P = 0.1).  
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Fig. 4.17. The extent of splenomegaly is dependent on the number of 40 bp units present in viral 
genome. C57BL/6 mice were infected with 5 x 104 PFU intranasally. The extent of splenomegaly was 
measured by taking the spleen weight of each mouse at day 17 post infection. The asterisk indicates a 
statistically significant decrease in the spleen weight of mice (Student’s t-test). Numbers in brackets 
represent the number of mice. Data (mean values ± SD) from two independent experiments are shown and 
in each experiment, 3-4 mice per group were used.  
 
In contrast, when compared to the spleen weight of mice infected with the 40 bp mutant 
virus, the difference was significant (M6 Stop mutant virus: P = 0.0003 and M6 Stop + 
Point mutant virus: P = 0.049). The ORF M6 mutant viruses caused a similar extent of 
splenomegaly as the 40 bp low mutant which has a similar number of repeat units (M6 
Stop mutant virus: P = 0.06 and M6 Stop + Point mutant virus: P = 0.7). Thus, the 
extent of splenomegaly was dependent on the number of 40 bp repeat units present in 
the viral genome and not on the expression of a putative M6 protein. 
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4.6.2. The 40 bp internal repeat of MHV-68, but not the ORF M6, is 
important for viral reactivation from latently infected splenocytes 
 
To analyze the role of ORF M6 in ex vivo reactivation, mice were infected with 5 x 104 
PFU intranasally, spleens were harvested on day 17 post infection, and an ex vivo 
reactivation assay was performed. From the panel of our ORF M6 mutants, we selected 
the ORF M6 Stop mutant and compared it to the different 40 bp mutants as well as to 
the parental virus. Splenocytes from mice infected with the parental virus or the 
different mutants reactivated to a similar extent but consistent with our previous results 
(Fig. 4.18), a reduction in reactivation was observed for the 40 bp mutant.  
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Fig. 4.18. The extent of ex vivo reactivation after infection of mice with an ORF M6 mutant. At day 
17 post infection, single cell suspensions of splenocytes from C57BL/6 mice infected with parental or 
different mutant viruses (40 bp moderate mutant virus, 40 bp low mutant virus, M6 Stop mutant virus, and 
40 bp mutant virus) were used for an ex vivo reactivation assay. Splenocytes from 3 mice per group were 
pooled and then three-fold serial dilutions were made. The different dilutions were co-cultured with NIH 
3T3 cells for three weeks and checked for cytopathic effects microscopically. The frequencies of cells 
which are reactivating from the latently infected splenocytes and entering the lytic phase of infection were 
calculated as described in 4.4.2. 
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Using splenocytes from infections with the 40 bp mutant virus, 1 in 4490 splenocytes 
reactivated (P = 0.04). The 40 bp moderate mutant showed a reactivation of 1 in 2057 (P 
= 0.05), the 40 bp low mutant of 1 in 1052 (P = 0.25), the M6 Stop mutant of 1 in 2077 
(P = 0.05) and the parental virus 1 in 1045. Thus, ORF M6 does not seem to be 
important for ex vivo reactivation from latently infected splenocytes. 
 
 
4.6.3. Determination of subsets of cells in the spleen of mice by FACS 
analysis 
 
As described above, mice infected with the 40 bp mutant virus displayed a significant 
decrease in the extent of splenomegaly compared to infection with parental virus. This 
reduction in the spleen weight could be due to a decrease in the activation and 
proliferation of cells in the spleen or lymphocyte recruitment to the spleen. Therefore, 
we analyzed the subsets of cells in the spleen by flow cytometry. We found that the 
relative proportion of CD4+, CD3+ and CD8Vβ4+ T cells was not significantly different 
in C57BL/6 mice infected with either parental virus or mutant viruses, i.e., 40 bp mutant 
virus, M6 Stop mutant virus and 40 bp low mutant virus (Fig. 4.19). This suggests that 
the decrease in the spleen weight of C57BL/6 mice infected with the 40 bp mutant virus 
is not due to a decrease in a particular cell population, but might be due to an overall 
decrease in the proliferation of cells in the spleen or in the recruitment of lymphocytes 
to the spleen. 
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Fig. 4.19 Lymphocyte subsets in the spleens of C57BL/6 mice infected with parental virus or mutant 
viruses (40 bp mutant virus, M6 Stop mutant, and 40 bp low mutant). Single cell suspensions from 
spleens were prepared and stained with monoclonal antibodies (MAbs) against cell type specific markers 
and fixed in 1% paraformaldehyde after staining. Splenocytes were stained for B cells (FITC anti mouse 
CD45R/B220), total T cells (FITC anti mouse CD3), cytotoxic T lymphocytes (FITC anti mouse CD8a), 
CD4+ T cells (FITC anti mouse CD4), and CD8Vβ4 T cells (PE anti mouse Vβ4 T-cell Receptor). 
Splenocytes from 3 mice per group were pooled and analyzed. Data shown are from a representative 
experiment which was repeated once with similar results. 
 
Summary for chapter 4.6 
1) The extent of splenomegaly depends on the number of 40 bp internal repeat units 
present in the MHV-68 genome. 
2) ORF M6 of MHV-68 has apparently no role in lytic replication in lungs or latent 
infection in the spleen. 
3) The reduction in the spleen weight of C57BL/6 mice infected with the 40 bp mutant 
virus is due to an overall decrease in all cell subsets contributing to the cellularity of 
the spleen. 
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4.7. In the absence of CD8+ T cells, the extent of splenomegaly 
induced by the 40 bp mutant virus is not significantly different 
from the parental virus 
 
It has been shown that during MHV-68 infection, CD8+ T cells are important for both 
the clearance of acute infection from the lungs and the long term control of persistent 
infection. Infectious virus is cleared from the lungs by CD8+ T cells and CD4+ T cells 
within 10-12 days post infection, however, the T cell response is apparently ineffective 
in preventing massive amplification of latently infected cells at germinal centres. We 
had observed that infection with the 40 bp mutant virus causes a reduced EBV-like 
infectious mononucleosis syndrome in mice, similar to what has been reported after 
infection of mice with ORF MK3 mutants and M3 mutants. Both the MK3 and the M3 
genes are involved in evasion from CD8+ T cell immunity (Bridgeman, Stevenson et al. 
2001; Stevenson, May et al. 2002). Additionally, the decreased reactivation from 
latently infected splenocytes in the case of the 40 bp mutant virus infection suggests an 
involvement of virus specific immune responses. Therefore, we investigated whether the 
40 bp internal repeat might play a role in escape from the CD8+ T cell immune response. 
For this purpose, CD8-/- mice, β2 microglobulin knockout mice as well as C57BL/6 
control mice were intranasally infected with 5 x 104 PFU of either parental or 40 bp 
mutant virus intranasally.  
The spleen weights of CD8-/- mice infected either with the parental virus or with the 40 
bp mutant virus were not significantly different (P = 0.117) (Fig. 4.20). In contrast, 
consistent with our previous results, there was a significant difference in the spleen 
weights of wild type mice infected with the 40 bp mutant virus (P = 0.0022) compared 
to those infected with the parental virus. Thus, in the absence of CD8+ T cells, the 
infection of mice with the 40 bp mutant led to a normal splenomegaly. However, the 
extent of splenomegaly in CD8-/- mice infected with parental virus was lower compared 
to C57BL/6 mice infected with parental virus (P = 0.038). There are two possible 
explanations for this observation: either, the absence of CD8+ T cells rescued the 
phenotype of the 40 bp mutant, or, infection with the parental virus lead to a reduced 
splenomegaly in CD8-/- mice compared to C57BL/6 wild type mice. To assess this 
further, similar experiments were performed in β2 microglobulin knockout mice which 
also lack CD8+ T cells. 
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Fig. 4.20. The absence of CD8+ T cells in mice abolishes the difference in splenomegaly after 
infection with parental virus or 40 bp mutant virus. C57BL/6 and CD8 T cell knockout mice (5 mice 
per group) were infected with 5 x 104 PFU intranasally. Spleens were harvested at day 17. Numbers in 
brackets represent the number of mice. Data (mean value ± SD) are compiled from two independent 
experiments and in each experiment 2-3 mice were used per group.  The asterisk indicates a statistically 
significant decrease in the spleen weight of C57BL/6 mice infected with the 40 bp mutant virus compared 
to the infection of C57BL/6 mice with the parental virus (P = 0.0022) (Student’s t-test). However, no 
significant difference in the spleen weight of CD8 T cell knockout mice was observed after the infection 
with the parental virus or the 40 bp mutant virus (P = 0.117). 
 
In β2 microglobulin knockout mice, the absence of CD8+ T cells again abolished the 
difference in splenomegaly between parental and 40 bp mutant (P = 0.34) (Fig. 4.21). In 
contrast to the CD8-/- mice, there was no reduced splenomegaly when compared to wild 
type mice (P = 0.689). This provides further evidence that in the absence of CD 8+ T 
cells, the extent of splenomegaly following infection with the 40 bp mutant virus and 
parental virus were not significantly different. 
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Fig. 4.21. The absence of CD8+ T cells in β2 microglobulin knockout mice leads to a reversal in the 
phenotype after infection with the 40 bp mutant virus. C57BL/6 mice (4 per group) and β 2 
microglobulin knockout mice (3 per group) were infected with 5 x 104 PFU intranasally. The spleen 
weight was taken at day 17 post infection. Numbers in brackets represent the number of mice. Data (mean 
valuse ± SD) are compiled from two independent experiments. The asterisk indicates statistically 
significant decrease in the spleen weight of C57BL/6 mice infected with the 40 bp mutant virus compared 
to the infection of C57BL/6 mice with the parental virus (P = 0.001). However, no significant difference 
in the spleen weight of β 2 microglobulin knockout mice was observed after the infection with the 
parental virus or the 40 bp mutant virus (P = 0.34). 
 
Summary for chapter 4.7 
In the absence of CD8+ T cells, the spleen weight of mice infected with the 40 bp mutant 
virus is comparable to the spleen weight of mice infected with the parental virus and 
therefore, the 40 bp internal repeat of MHV-68 might have role in escaping the immune 
response  mediated by CD8+ T cells. 
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4.8. The 40 bp internal repeat of MHV-68 is involved in the 
regulation of the expression of the MK3 gene 
 
Compared to infection with the parental virus, infection of C57BL/6 mice with the 40 bp 
mutant virus caused both a decrease in the extent of splenomegaly as well as a 2-2.5 fold 
decrease in the extent of reactivation of latent virus. However, this phenotype was 
reversed in CD8 T cell knockout mice (4.20 & 21). Similar observations have been 
reported after the infection of mice with MK3-deficient MHV-68 (Stevenson, May 
2002). MK3 plays an important role in evasion from CD8+ T cell responses against 
MHV-68. The 40 bp internal repeat is located 1067 bp upstream of the 5’ end of the 
ORF MK3 start codon (nucleotide position 25335) (Fig. 4.22). Therefore, we 
hypothesized that the 40 bp internal repeat might potentially influence the expression of 
MK3. To investigate this hypothesis, we analysed the expression of MK3 by RT-PCR in 
fibroblasts (NIH 3T3), where the virus undergoes lytic replication, and in the B cell line 
Ag8, where MHV-68 establishes a latent infection.  
 
MK313 MPromotor
1067 bp
40 bp repeats
Transcription start site
 
Fig. 4.22. Schematic presentation of the organization and position of ORF 13M/MK3 and the 40 bp 
internal repeat region of MHV-68. The 40 bp internal repeat of MHV-68 is present at the 5’ end of ORF 
13M/MK3. The start codon of ORF 13M/MK3 and the 40 bp internal repeats are separated by 1067 bp.  
 
We infected fibroblasts and B cells with either parental virus or the 40 bp mutant virus 
with an M.O.I of 1. The expression of ORF MK3 was evaluated by isolation of RNA 
from infected cells and subsequent semiquantitative RT-PCR and real-time RT-PCR. To 
estimate the genomic load of latent virus, DNA was isolated from the Ag8 B cell line 
infected with the parental virus and the 40 bp mutant and subjected to real-time PCR 
analysis.  
In the fibroblast cell line, no significant difference in the expression of MK3 was found 
after infection with either the 40 bp mutant or the parental virus 24 hours post infection 
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(Fig. 4.23). To exclude viral DNA contamination of the RNA extracted from infected 
cells, RT-PCR reactions without reverse transcriptase were run as controls. They yielded 
no PCR products (not shown). The expression of the house keeping gene elongation 
factor 1 β was used as a control of equal amounts of input cDNAs. 
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Fig. 4.23. The deletion of the 40 bp internal repeat of MHV-68 has no influence on the expression of 
the neighboring gene MK3 in fibroblasts. The expression of MK3 was analysed by RT- PCR and 
visualized on an ethidium bromide stained 1% agarose gel. RNA was prepared from NIH 3T3 cells 
infected with the parental virus or the 40 bp mutant or from uninfected cells, and cDNA was prepared 
from 2 μg of DNase treated RNA. The conditions for PCR were as follows: initial denaturation at 94oC 
for 3 min followed by 30 cycles of 94oC denaturation for 30 sec, 55oC annealing for 30 sec and 72oC 
synthesis for 30 sec. A house keeping gene elongation factor 1 β was amplified by PCR to check the input 
of cDNA. Also, control reactions without reverse transcriptase were included to check for the presence of 
genomic DNA, and yielded no PCR products (not shown). In the uninfected sample, only unspecific PCR 
products were observed after performing the PCR with primers for MK3 gene. 
 
In contrast to the fibroblasts, MK3 expression in the B cell line Ag8 was substantially 
higher following infection with either the parental virus or 40 bp revertant virus as 
compared to infection with the 40 bp mutant. The expression of a house keeping 
gene (GAPDH) was similar (Fig. 4.24)  
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Fig. 4.24. The deletion of the 40 bp internal repeat of MHV-68 leads to a reduced expression of the 
neighboring gene MK3 in B cells (Ag8). (a) The expression of MK3 was analyzed by RT- PCR and 
visualized on an ethidium bromide stained 1% agarose gel. RNA was prepared from the B cell line Ag8 
infected with the parental virus or the 40 bp mutant or the 40 bp revertant virus. A house keeping gene 
GAPDH was amplified by PCR to check the input of cDNA. Also, control reactions without reverse 
transcriptase were included to check for the presence of genomic DNA, and yielded no PCR-products (not 
shown). The conditions for PCR reaction were similar as implied for checking the expression of ORF M6 
in fibroblasts. For the estimation of MK3 expression, the PCR was performed using 2 μl of cDNA. The 
cDNA was prepared from 2 μg of RNA sample. 
 
These results were confirmed by real time RT-PCR analysis. It was found that in the B 
cell line Ag8, the expression of MK3 in cells infected with the parental virus is 7-8 fold 
higher than in those infected with the 40 bp mutant (Fig. 4.25). To exclude that the 
reduction is not just due to a lower infection rate, we determined the total latent genomic 
load of parental virus as well as of the 40 bp mutant in the B cell line Ag8. 
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Fig. 4.25. The deletion of the 40 bp internal repeat of MHV-68 leads to a reduced expression of the 
neighboring gene MK3 in B cells (Ag8). (a) Estimation of the expression of MK3 in Ag8 cell line by 
real-time PCR. For the estimation of MK3 expression, the PCR was performed using 2 μl of cDNA in a 
20 μl system. The cDNA was prepared from 2 μg of RNA from infected B cells. The expression of MK3 
was estimated as relative copy number of MK3 cDNA per copy number of rpl8 cDNA. The copy number 
of MK3 was estimated against a standard curve constructed by serial dilution of MHV-68 BAC plasmid 
containing the ORF MK3. The amount of cDNA was also confirmed by the estimation of the murine 
ribosomal protein L8 (rpl8) gene by real time PCR.  The standard curve for rpl8 was constructed by serial 
dilution of a plasmid containing a 163 bp fragment of rpl8 (pCR2.1/rpl8) (Stewart et al. 2004). The PCR 
products from the real time PCR were visualized on an ethidium bromide stained 1% agarose gel. (b) 
Estimation of the latent genomic load in the Ag8 cell line by real-time PCR. The real time PCR was 
performed with 200 ng of total Ag8 cell DNA using primers specific for the MHV-68 ORF 50 gene and 
L8 (cellular) to estimate the latent viral genome load in the Ag8 cells. The MHV-68 genome copy number 
was estimated against a standard curve constructed by serial dilution of plasmid pUC19 ORF50 (Eco RI – 
Ava I fragment, nucleotide position 65707-69550 of MHV-68). The copy number of rpl8 was estimated 
against a standard curve constructed by serial dilution of plasmid containing a 163 fragment of rpl8.  
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Consistent with our in vivo genomic load experiments (Fig.4.15), the latent viral genome 
load was found to be similar after infection with either the 40 bp mutant or the parental 
virus. We also demonstrated that the amount of template DNA used for the PCR was 
similar as assayed by amplifying a genomic region within the murine ribosomal protein 
coding gene L8 (Fig. 4.25). These data indicate that the infectivity of both viruses was 
similar. This suggests that the expression of MK3 in the B cell line Ag8 is reduced in the 
presence or absence of the 40 bp internal repeat and may thus explain the phenotype of 
reduced splenomegaly in CD8 expressing mice. B cells are a major reservoir for MHV-
68 latent infection, and the expression of the MK3 protein may protect against CD8+ T 
cell immunity. Thus, in the absence of the 40 bp internal repeat the expression of MK3 
is down-regulated which in turn leads to enhanced antiviral CTL responses, impaired 
expansion of latently infected cells in lymphoid germinal centers and an attenuation of 
the MHV-68-induced splenomegaly. 
 
Summary for chapter 4.8 
1. In the fibroblast cells, the expression of ORF MK3 is independent of the presence of 
the 40 bp internal repeat of MHV-68. 
2. In the B cell line, the expression of ORF MK3 is dependent on the presence of the 40 
bp internal repeat in the genome of MHV-68. Thus, the 40 bp internal repeat is 
involved in regulation of expression of MK3 in a tissue specific or infection cycle 
specific fashion. 
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5.0. Discussion 
 
One of the common features of gamma herpesviruses is the presence of various kinds of 
repeats in their genome. Usually, the unique region of the genome which codes for most 
of the genes is flanked by terminal repeats and interspersed by many internal repeats. In 
Epstein-Barr virus, there are four different internal repeats termed IR1-4. The IR3 repeat 
plays a role in the evasion from the immune response (Levitskaya et al. 1995; 1997; 
Sharipo et al. 1998), and some repeats (IR2 and IR4) are part of the origins of lytic 
replication (Hammerschmidt and Sugden 1988). The HHV-8 genome has approximately 
six internal repeats and two repeats, like in EBV, are part of the origins of lytic 
replication (AuCoin et al. 2002). However, the role of the gamma herpesvirus repeats in 
pathogenesis is not clear.  
MHV-68 which is considered to be a model for gamma herpesvirus pathogenesis has 
two internal repeats, i.e., the 40 bp repeat and the 100 bp repeat. The 100 bp repeat is 
located at the right side of the genome (nucleotide positions 98981-101170) and consists 
of approximately 21 copies of 100 bp repeat units. The 100 bp repeat is part of three 
overlapping ORFs: ORF M10a, ORF M10b and ORF M10c. It has been shown that the 
100 bp repeat contributes to the lytic origin of replication at the right side of the MHV-
68 genome (Deng et al. 2004).  
The 40 bp internal repeat of MHV-68 is located at the left side of the genome 
(nucleotide positions 26778-28191). It consists of approximately 36 copies of 40 bp 
repeat units, some of which can vary in their sequence (Virgin et al. 1997). The 40 bp 
internal repeat is also part of a hypothetical ORF M6 (Virgin et al. 1997).  
In this study, we addressed the role of the 40 bp internal repeat and/or ORF M6 in in 
vitro replication and in pathogenesis. 
 
 
5.1. Construction of the 40 bp and ORF M6 mutant viruses 
 
To analyze the role of the 40 bp internal repeat and/or ORF M6, six independent 
mutants were constructed by the different methods using MHV-68 cloned as a BAC. To 
study the role of the 40 bp internal repeat and to determine the significance of the 
number of the 40 bp internal repeat units, we constructed three viral mutants, i.e., the 40 
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bp mutant virus, the 40 bp moderate mutant virus and the 40 bp low mutant virus. The 
40 bp mutant virus contains a deletion of all the 40 bp internal repeat units which was 
confirmed by restriction enzyme analysis and sequencing of the 40 bp internal repeat 
region. The 40 bp low mutant contains 15 copies of 40 bp internal repeat units as 
determined by restriction enzyme analysis and sequencing. The 40 bp moderate mutant 
virus has approximately 20-25 copies of the 40 bp repeat units as determined by 
restriction enzyme analysis (Fig. 4.3 & 4). Probably due to the formation of secondary 
structures in the 40 bp repeat region, sequencing of the 40 bp moderate mutant was not 
possible and thus, the precise number of 40 bp internal repeat units present in the 40 bp 
internal repeat region could not be determined. Virgin et al. proposed that the 40 bp 
internal repeat contains approximately 36 copies of repeat units, however it was not 
possible to stably clone and sequence the 40 bp internal repeat region (Virgin et al. 
1997). To ensure that there are no rearrangements and/or mutations outside the 40 bp 
internal repeat region created during mutagenesis, a revertant virus was generated by 
replacing the 40 bp mutant fragment with the wild type genomic fragment. 
In addition, we constructed three viral mutants to study the role of ORF M6, i.e., M6 
Stop mutant virus, M6 Point mutant virus, and M6 Stop + Point mutant virus. M6 Stop 
mutant virus contains stop codons in all three possible open reading frames at the Hind 
III site (nucleotide position 26711) which lead to the termination of ORF M6 translation 
after 31 amino acids. Since the M6 Stop mutant virus can still encode for 31 amino acids 
present at the N-terminus of ORF M6, we inserted a point mutation in the start codon 
(ATG to ACG) of ORF M6 leading to the formation of M6 Point mutant virus. Thus, 
ORF M6 cannot be translated. We also constructed a double mutant virus, i.e., M6 Stop 
+ Point mutant virus, which contains a mutation at the start codon and additionally an 
insertion of stop codons in all three possible open reading frames. It has been reported 
that the 40 bp internal repeat is unstable in the MHV-68 BAC and can lead to an 
unwanted loss of the 40 bp internal repeat in E. coli (Adler et al. 2000; 2003). Indeed, it 
was not possible to construct the ORF M6 mutants without losing some of the 40 bp 
internal repeat units. The three ORF M6 mutant viruses and the 40 bp low mutant virus 
have a similar number of repeats as determined by restriction enzyme analysis. 
Therefore, the phenotype of the ORF M6 mutant viruses can be compared to the 40 bp 
low mutant virus. Transfection of all the mutant MHV-68 BAC plasmids into fibroblasts 
allowed reconstitution of lytic viruses, which shows that neither the 40 bp repeat nor 
ORF M6 are essential for virus replication in cell culture. 
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5.2. The 40 bp internal repeat of MHV-68 is dispensable for lytic 
replication both in vitro and in vivo  
 
Infection of NIH 3T3 cells at low MOI (0.1) showed that all mutant viruses efficiently 
replicated and attained similar titers when compared to the parental virus (Fig. 4.8). The 
replication efficiency of the 40 bp mutant in the initial phase of infection (24 and 48 
hours post infection) appeared to be slightly reduced; however, at later time points (72 
and 96 hours post infection) it attained similar titers as the parental virus. It was also 
observed that the plaque size after infection with the mutant viruses was similar to the 
parental and revertant viruses. The replication efficiency of the 40 bp mutant or the ORF 
M6 mutants in the lungs of C57BL/6 mice was not significantly different to the parental 
and revertant virus (Fig. 4.10), indicating that the 40 bp internal repeats and/or ORF M6 
are dispensable for lytic replication in the lungs.  
It has been proposed that the ORF M6 region (containing the 40 bp internal repeat) 
might contain a second MHV-68 lytic origin of replication (Coleman et al. 2004). A part 
of the M6 coding region (nucleotide positions 26232-26374) has more than 70% 
homology to nucleotide positions 101624 to 101765 of the MHV-68 genome. The latter 
region neighbouring the 100 bp internal repeat harbors a known origin of lytic 
replication (Deng et al. 2004). Both loci have A/T-rich and G/C-rich regions 
characteristic of herpesvirus lytic origins of replication, and this function has also been 
confirmed for the equivalent regions of HHV-8 and RRV (AuCoin et al. 2002; Deng et 
al. 2004; Pari et al. 2001). In the prototype EBV genome, there are two copies of ori 
Lyt, called DS-L (Dyad symmetry left) and DS-R (right). However, it was shown that 
one copy is sufficient for lytic-cycle replication of EBV strain B95-8 (Fixman et al. 
1992; Laux et al. 1985). It was proposed that the presence of more than one origin of 
DNA replication (ori) might provide some replicative advantage for large DNA 
genomes compared to genomes with a single ori. Multi-ori genomes are less sensitive to 
mutations in one ori and the initiation of replication from more than one genome locus 
might result in an accelerated speed of replication (Jehle 2002). Preliminary experiments 
with double knockout mutants, i.e., mutants containing a deletion of the 40 bp internal 
repeat as well as the 100 bp internal repeat have shown that the double knockout mutant 
has a very low replication efficiency compared to mutants carrying a deletion in either 
of the two internal repeats (Adler et al., unpublished results). The 100 bp internal repeat 
region of MHV-68 acts as an auxiliary element to enhance the replication efficiency of 
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MHV-68 (Deng et al. 2004). It is likely that the 40 bp internal repeat contains sequences 
involved in lytic replication, but the presence of the other origin of lytic replication in 
the 100 bp repeat region might compensate for the loss of the sequences in the 40 bp 
internal repeat region. This is most likely the reason why little to no replication 
deficiency was observed in the in vitro replication of the 40 bp mutant virus.  
 
 
5.3. The 40 bp internal repeat of MHV-68 is important for the 
latent phase of infection 
 
MHV-68 establishes a latent infection in lymphocytes and drives the proliferation of 
infected lymphocytes during the establishment and maintenance of a large reservoir of 
latent viral genomes. The colonization of lymphoid tissue by MHV-68 is a complex 
process which involves multiple cell types including B lymphocytes, macrophages, 
dendritic cells and some epithelial cells with different programs of viral gene expression 
(Virgin et al. 1999). To study the role of the 40 bp internal repeat for the latent phase of 
infection, we used different methods to measure viral latency: the extent of 
splenomegaly, the extent of ex vivo reactivation as well as the genomic load of latent 
virus in splenocytes.  We found that infection of C57BL/6 mice with the 40 bp mutant 
during the amplification stage of the latency (day 13 and 17 post infection) caused 
significantly less splenomegaly and a reduced frequency of ex vivo reactivating 
splenocytes, when compared to the infection with parental virus (Fig. 4.11 and 14). 
However, this phenotype was not observed during the initial stage of latency 
establishment (day 10) and the long term latency (day 23 and 42).  
During the amplification stage of latency, the splenocytes from mice infected with the 
40 bp mutant virus showed a decrease in the extent of reactivation compared to 
splenocytes from mice infected with parental virus. We checked whether this decrease 
in the extent of reactivation from splenocytes of mice infected with the 40 bp mutant 
was due to either a defect in the reactivation process per se or a decrease in the number 
of latently infected cells in the spleen. Using real time PCR, we estimated the latent 
genomic load in the spleens of mice infected with the 40 bp mutant virus or the parental 
virus. At day 17 and 42 post infection, real time PCR analysis showed that there was no 
significant difference in the viral genome copy number per 100 ng of total DNA after 
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infection with either the parental virus or the 40 bp mutant (Fig. 4.15). However, since 
the total spleen weights as well as the total number of splenocytes are higher after 
infection with the parental virus at day 17 post infection, the overall latent genomic load 
in the spleen of mice infected with the parental virus is higher. At day 42, where no 
difference in the spleen weight or extent of reactivation was observed, the overall latent 
genomic load in the spleen of mice infected with either virus is similar. These data 
suggest that the 40 bp internal repeat of MHV-68 is important for pathogenesis, 
especially for the amplification stage of the latency but not for long-term persistent 
infection. The internal repeats of HSV also play an important role in pathogenesis. It has 
been shown that the deletion of internal repeats from the HSV genome results in a 
pronounced effect on neurovirulence, neuroinvasivness and in the ability to establish a 
reactivable latent infection in mice (Jenkins et al. 1996). 
We found that the extent of splenomegaly is dependent upon the number of 40 bp 
internal repeat units present in the MHV-68 genome (Fig. 4.17). Thus, the highest 
spleen weight was observed in mice infected with the parental virus which contains all 
the repeat units, followed by the 40 bp moderate mutant virus which has lost a few 
repeat units, and the 40 bp low mutant which has lost a considerable number of repeat 
units. The lowest spleen weight was found in mice infected with the 40 bp mutant virus 
in which all the repeat units were deleted. The extent of splenomegaly was found to be 
not associated with the expression of the hypothetical ORF M6, as the mice infected 
with the ORF M6 mutant viruses showed no significant difference in the spleen weight 
when compared to the parental virus but a significant difference when compared to the 
40 bp mutant virus. 
 
 
5.4. In the absence of CD 8+ T-cells, the 40 bp mutant causes a 
similar extent of splenomegaly  
 
CD8+ T cells play a major role in controlling the acute lytic infection that follows 
primary MHV-68 infection; however, the CD8+ T cell response is ineffective in 
preventing the massive proliferation of latently infected B cells in germinal centers 
(Ehtisham et al. 1993; Weck et al. 1996; Stevenson et al. 1999 b; 2002 a). This suggests 
 97
                                                                                                                                  Discussion 
that MHV-68 has evolved a mechanism to evade CD8+ T cell immunity by which it can 
achieve the burst of lymphocyte proliferation that initially establishes the latent pool.  
So far, two MHV-68 genes, i.e., M3 and MK3, have been identified which play 
important roles in the evasion of CD8+ T cell mediated immunity. The mutant viruses 
for these genes show normal lytic replication in the lungs; however, they have enhanced 
CTL responses, impaired expansion of latently infected cells in lymphoid germinal 
centers and an attenuation of the MHV-68-induced infectious mononucleosis. In vivo, 
the defect in the amplification of latency is largely reversible by CD8+ T cell depletion 
(Bridgeman et al. 2001; Stevenson et al. 2002 a). Infection of C57BL/6 mice with the 40 
bp mutant caused significantly less splenomegaly and a reduced frequency of ex vivo 
reactivating splenocytes, when compared to the infection with parental virus. This 
phenotype was similar to the phenotype which has been reported after infection of mice 
with ORF MK3 mutant viruses and M3 mutant viruses. Therefore, we considered the 
possibility that the 40 bp internal repeat might also play a role in the evasion of CD8+ T 
cell mediated immunity. To address this possibility, we infected mice lacking CD8+ T 
cells (CD8+ T cell knockout mice) and parental C57BL/6 mice with either the 40 bp 
mutant or the parental virus and measured the extent of splenomegaly. CD8+ T cell 
knockout mice lack mature CD8+ T cells, due to disruption of CD8 genes (Lyt-2 and 
Lyt-3). It has been shown that in vivo, CD8 expression is necessary for the development 
of MHC class I-restricted cytotoxic T cells and hence, these mice have impaired CD8+ T 
cell mediated immunity (Fung-Leung et al. 1991). These mice have been used to 
evaluate the role of CD8+ T cells during viral infection (Kimura and Griffin 2000; Liu 
and Chamber 2001; Nass et al. 2001; Xu et al. 2004). We found that the spleen weights 
of CD8+ T cell knockout mice infected with either the parental virus or the 40 bp mutant 
virus were not significantly different (Fig. 4.20). Yet the weight of the spleen infected 
with parental virus was lower than in wild type mice. The reason for this difference is 
not clear. The lower spleen weight of CD8+ T cell knockout mice after infection with 
parental virus might be due to the absence of CD8+ T cells which also contribute to the 
splenomegaly. Such a difference has not been reported by other laboratories (Bridgeman 
et al. 2001; Stevenson et al. 2002 a). However, in their experiments, CD8+ T cells were 
depleted from wild type mice by injection of monoclonal antibodies. Since there are no 
reports in the literature on the extent of splenomegaly in CD8+ T cell knockout mice, we 
could not really compare our findings to published data. Therefore, to confirm our 
results from the CD8+ T cell knockout mice experiments, we performed similar 
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experiments in β2 microglobulin knockout mice. β2 microglobulin knockout mice lack 
efficient surface major histocompatibility complex class I expression as a result of a null 
mutation in the β2 microglobulin gene (Koller et al. 1990), with consequent deficiency 
in CD8+ T cells (Doherty et al. 1993; Hou et al. 1992; Lehmann-Grube et al. 1993; 
Matloubian et al. 1994; Muller et al. 1992). Apart from classical MHC-I molecules, 
several other non-classical MHC class I-related molecules (Qa, h2-M3, and Cd1) require 
β2 microglobulin for their expression and recognition of foreign antigens or altered self 
antigens (Kronenberg et al. 1999). β2 microglobulin knockout mice have been 
extensively used by others to investigate the role of CD8+ T cells in viral infection 
(Doherty et al. 1993; Lehmann-Grube et al. 1993; Muller et al. 1992). It has been shown 
that the spleen weights of β2 microglobulin knockout mice and parental C57BL/6 mice 
are not significantly different after infection with MHV-68 (Weck et al. 1996). 
Consistent with this report (Weck et al. 1996), we found no significant difference in the 
spleen weight of the two strains of mice (β2 microglobulin knockout mice and parental 
C57BL/6 mice) (Fig. 4.21). Also, consistent with our CD8+ T cell knockout mice 
experiments, no significant difference in the spleen weight of β2 microglobulin 
knockout mice after infection with either the parental virus or the 40 bp mutant virus 
was observed.  
In contrast to the CD8+ T cell knockout mice which lack CD8+ T cells only, β2 
microglobulin knockout mice have no MHC class I protein expression on the cell 
surface. In β2 microglobulin knockout mice, a compensatory increase in CD4+ T cells 
has been observed (Fung-Leung et al. 1991). It is known that after infection of mice 
with MHV-68, the induction of splenomegaly, B cell proliferation, maturation, and 
activation are dependent on CD4+ T cells (Cardin et al. 1996; Sangster et al. 2000; 
Stevenson and Doherty 1999; Usherwood et al. 1996 a). Therefore, it is possible that 
after MHV-68 infection there is an increase in CD4+ T cells in β2 microglobulin 
knockout mice. This might induce the proliferation of B cells and thus splenomegaly 
similar to C57BL/6 mice, even in the absence of CD8+ T cells which also contribute to 
the transient splenomegaly.  
It has been shown that the CD1 molecule requires β2 microglobulin to be expressed 
(Brutkiewicz et al. 1995). CD1 molecules are MHC class I-like transmembrane 
glycoproteins that are encoded by a family of genes located outside of the classical MHC 
loci (Porcelli and Modlin 1999). CD1 is required for the development of a subset of 
specialized T cells, termed NKT cells, which express the semivariant Vα14-Jα281 TCR 
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(T cell receptor) paired with Vβ8.2-7 or -2 (Bendelac et al. 1997). This natural T-cell 
subset occurs in both mice and humans, and responds rapidly to stimulation by the 
release of cytokines; as a result, it is thought to represent a bridge between the innate and 
the acquired immune response (Porcelli and Modlin 1999). CD1 and/or NKT cells have 
been implicated in immunity to a number of pathogens (Denkers et al. 1993; Gonzalez-
Aseguinolaza et al. 2000; Kakimi et al. 2000; Pied et al. 2000) and in case of HSV, it 
has been shown that CD1d and CD1d-restricted NKT cells are important in the control 
of infection and in clearance of the virus (Ashkar and Rosenthal 2003; Grubor-Bauk et 
al. 2003). Therefore, it is possible that in CD8+ T cell knockout mice after infection with 
parental virus, CD1-restricted NKT cells clear a small fraction of latently infected cells 
and thus the mice have less splenomegaly compared to that observed after infection of 
β2 microglobulin knockout mice with parental virus, as β2 microglobulin is required for 
the expression of CD1.  
Keeping the above considerations in mind, we nevertheless conclude from our 
experiments that the absence of CD8+ T cells largely reversed the phenotype of the 40 
bp mutant virus. In other words, in mice deficient of CD8+ T cells, infection with the 40 
bp mutant causes splenomegaly to a similar extent as infection with parental virus. Thus, 
a major role of the 40 bp internal repeat of MHV-68 in vivo seems to be to prevent CTL 
recognition during the amplification stage of latency (2-3 weeks post infection) which is 
important for host colonization. Although latency amplification is not essential for 
persistence and reactivation per se (Stewart et al 1998), it probably increases viral 
seeding to systemic sites and makes long-term viral transmission more robust in 
immunocompetent hosts (Stevenson et al. 2002 b). 
 
 
5.5. The 40 bp internal repeat of MHV-68 is involved in the 
establishment of latency by regulating the expression of MK3 in a 
tissue specific/infection cycle specific fashion 
 
The establishment of latency provides unique advantages for herpesviruses to escape 
host immune surveillance and to establish lifelong persistent infection. Latency of 
gamma herpesviruses is characterized by silencing of most of their genes present in the 
genome. One critically important regulatory mechanism utilized by gamma 
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herpesviruses is DNA methylation. It has been shown that methylation of cytosines 
within CpG dinucleotides at the promotor regions of EBV are important for gene 
silencing and genome integrity to maximize persistence and hide from immune 
detection (Ernberg et al. 1989; Minarovits et al. 1994; Paulson and Speck 1999; 
Salamon et al. 2001; Tao and Robertson 2003). However, to maintain latency, gamma 
herpesviruses encode a limited number of genes which can play an important role in 
immune evasion and maintenance of episomal DNA. It has been shown that three 
distinct regions of the MHV-68 genome are transcriptionally active during the latent 
phase of infection. The location of these regions correlates well with regions in HHV-8, 
EBV and HVS that contain known latency and/or tumor-associated genes, and some of 
the ORFs in these regions are homologous to known latency- or tumor-associated genes 
of EBV, HVS, or HHV-8 (Virgin et al. 1999). Two of these genes (M3 and MK3) are 
involved in the evasion of CTLs to achieve the burst of lymphocyte proliferation that 
initially establishes the latent pool (Bridgeman et al. 2001; Stevenson et al. 2002 a). The 
MHV-68 MK3 protein contributes to this process in vivo by evading CD 8+ T cell 
recognition during latency as well as during lytic infection. A major feature of the MK3-
deficient MHV-68 phenotype is a defect in viral latency amplification (Stevenson et al. 
2002 a). MK3 is transcribed as part of a bicistronic mRNA, downstream of ORF 13M 
(Fig. 4.22) (Coleman et al. 2004) and it is classified as an immediate early gene (Virgin 
at al. 1997; Ahn et al. 2002). In functional terms, 13M and MK3 are controlled by the 
same promoter elements (genomic coordinates 25735 to 26778) which are located at 1 
kbp 5’ of the transcription start site. It has been demonstrated that the dependence of 
ORF MK3 expression on the ORF 50 lytic transactivator (Rta) varies, depending upon 
the cell line in which it is tested (Coleman et al. 2004). ORF 50 (Rta) of MHV-68 is 
homologous to the Rta genes of other gamma herpesviruses, including HHV-8 and 
EBV. Transfection of HHV-8 and MHV-68 Rta expressing plasmids into latently 
infected cell lines has been shown to activate expression of early and late viral lytic 
genes (Lukac et al. 1998; Sun et al. 1998) and can induce viral lytic DNA replication 
and virus production  in MHV-68 (Wu et al. 2000). It has been proposed that during de 
novo infection of permissive cells, Rta can be activated by cooperative action of a virion 
protein similar to HSV VP16 and cellular transcription factors. In nonpermissive cells, 
Rta expression is blocked, thus preventing the initiation of the viral lytic cascade, 
leading to latency (Wu et al. 2000). 
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In our studies, infection of C57BL/6 mice with the 40 bp mutant led to a significant 
decrease in the extent of splenomegaly, and this phenotype was reverted in mice lacking 
CD8+ T cells. This phenotype is comparable to the phenotype observed after infection of 
mice with the MK3 deficient MHV-68. Also, we have shown that the extent of 
splenomegaly is not dependent on ORF M6 protein expression, but depends on the 
number of 40 bp internal repeats present in the MHV-68 genome. Therefore we 
analyzed whether the 40 bp internal repeats of MHV-68 affect the expression of the 
MK3 gene as they are located at the 5’ end of the ORF 13M/MK3 promotor. We found 
that in fibroblasts (NIH 3T3), expression of the MK3 gene after infection with the 40 bp 
mutant was unaffected, whereas in the B cell line Ag8, a marked reduction of MK3 
expression was observed (Fig. 4.23, 24 & 25). These data indicated that expression of 
MK3 might be differentially regulated during lytic replication and latent phase of the 
infection.  
It is likely that in fibroblasts, where MHV-68 replicates lytically, Rta cooperates with 
some transcriptional factors and/or viral genes leading to the expression of 13M/MK3. 
However, in the latent phase of infection where the expression of Rta has not been 
detected (Rochford et al. 2001; Virgin et al. 1999), MHV-68 could use the 40 bp 
internal repeat to regulate the expression of 13M/MK3 expression by recruiting 
additional transcription factors. It is quite likely that the 40 bp repeat might act as an 
enhancer for the expression of ORF MK3 during the latent phase of infection (Fig. 5.1). 
Transcriptional enhancers are discrete DNA elements that contain specific sequence 
motifs with which DNA-binding proteins interact and transmit molecular signals to 
genes. Enhancer sequences are part of transcriptional control regions that might be 
present in multiple copies and are often called enhancer modules. Each of these modules 
is designed to perform a specific function, such as the activation of its cognate gene in a 
specific cell type or at a particular stage in development (Blackwood and Kadonga 
1998). 
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Fig. 5.1. Hypothetical model for the function of the 40 bp internal repeat of MHV-68. 13M/MK3 
expression is regulated differentially in fibroblasts and B cells. During lytic replication in fibroblasts, the 
13M/MK3 promotor utilizes the aid of Rta complexes for its expression, whereas in B cells, it might 
utilize the 40 bp internal repeat as an enhancer for its expression. 
 
 
Similar enhancer elements containing repeat structures or multiple enhancer modules 
have been reported in many viruses. In murine leukemia virus (MuLV) and other non-
acute retroviruses, it has been shown that these enhancer sequences are important 
determinants of both the pathogenic potential and disease specificity of the respective 
viruses (Chatis et al. 1984; DesGroseillers and Jolicoeur 1984; Golemis et al. 1989; 
Holland et al. 1989; Li et al. 1987). In case of cytomegalovirus, the major immediate 
early promotor (MIEP) enhancer is required for optimal infection and plays an important 
role in determining the cell type tropism (Baskar et al. 1996 a and b; Koedood et al. 
1995). It has been suggested that enhancers affect pathogenicity by modulating the level 
of transcription of viral and cellular genes in a tissue specific fashion. Transient 
transfections of a number of different fibroblast and haematopoietic cell lines with 
MuLV-derived enhancer and promoter regions driving reporter genes have shown that 
LTR-mediated transcriptional activity correlates with the tissue specificity and disease-
inducing potential of the virus (Celander and Haseltine 1984; Nishigaki et al. 1997; 
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Short et al. 1987; Speck et al. 1990). The enhancer sequences of non-defective Friend 
and Moloney virus consist of densely packed series of motifs which contain actual or 
putative binding sites for cellular proteins and transcription factors (Golemis et al. 1990) 
It has been shown that the triplication of viral enhancer elements in Type B 
leukemogenic virus (TBLV) leads to upregulation of reporter gene activity and its 
enhancer activity is relatively orientation independent (consistent with the activity of 
eukaryotic enhancer elements). However, the enhancer activity is dependent on the cell 
type (Mertz et al. 2001). In case of MHV-68, there are approximately 36 copies of the 
40 bp internal repeat units, and therefore it is likely that MHV-68 requires many copies 
of these repeats for efficient transcription of 13M/MK3 during latency amplification. 
This is consistent with our observation that with the decrease in the number of 40 bp 
internal repeat units in the MHV-68 genome, the extent of splenomegaly after the 
infection also decreases (Fig. 4.17). Thus, the 40 bp internal repeat of MHV-68 could 
act as an enhancer sequence for the expression of MK3 in a dose dependent manner 
during the amplification stage of the latency.  
 
 
5.6. Outlook 
 
Infection of mice with murine gamma herpesvirus 68 (MHV-68) presents the 
opportunity to evaluate the role of specific immune system genes and individual gamma 
herpesvirus genes in a small animal model amenable to both genetic and pathogenetic 
studies. The MHV-68 genome contains two internal repeats, i.e., the 40 bp internal 
repeat and the 100 bp internal repeat. We wanted to study the role of these repeats in 
gamma herpesviruses pathogenesis and immunity. We have shown that the 40 bp 
internal repeat is important for the latent phase of infection, especially for the 
amplification of latency by regulating the expression of MK3. We have shown that in 
the B cell line Ag8, the expression of MK3 is dependent on the presence of the 40 bp 
internal repeat in the MHV-68 genome. However, it is not known whether the regulation 
of the expression of MK3 by the 40 bp internal repeat in vivo is dependent on the cell 
type or on the phase of infection. Studies of the expression of MK3 in various cell types 
(macrophages and dendritic cells), where MHV-68 can establish latent infection, and in 
in vivo samples could perhaps define the 40 bp internal repeat dependent ORF MK3 
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expression in a tissue specific/infection cycle specific fashion. The study of DNA-
protein interaction, i.e., of proteins or transcription factors binding to the 40 bp internal 
repeat region, would help to better understand the molecular mechanism by which the 
expression of ORF MK3 is regulated, interpreting the function of MK3 and relating this 
to immune evasion by other gamma herpesviruses. 
Our initial data also indicate that the 40 bp internal repeat of MHV-68 could be a part of 
a lytic origin of replication. Identification of a second MHV-68 origin of lytic 
replication (ori Lyt) and mapping the ori Lyt through deletion analysis will help to 
understand the biology of MHV-68 replication and also for the development of MHV-68 
based amplicon vectors. 
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6. Summary 
 
Gamma herpesvirus genomes have been observed to contain different kinds of repeat 
sequences, the functions of which range from immune evasion to being a part of the 
lytic origin of replication. The MHV 68 genome also contains two such internal repeats. 
In this study, we addressed the role of the 40 bp internal repeat and the hypothetical 
ORF M6 (which contains the 40 bp repeat) in in vitro replication and pathogenesis in 
mice. 
The 40 bp internal repeat and/or ORF M6 of MHV-68 are dispensable for lytic 
replication both in vitro and in vivo, however, it might be possible that the 40 bp internal 
repeat contains sequences involved in lytic replication, i.e., an origin of lytic replication. 
The 40 bp internal repeat plays an important role for the amplification of latency, as 
demonstrated by the reduction in the extent of splenomegaly and reduced reactivation. 
This phenotype is dependent on the number of 40 bp internal repeat units present in the 
genome, and is not associated with expression of ORF M6. During latency, the 
expression of the MHV-68 ORF MK3, known for its role in immune evasion, is reduced 
in the absence of the 40 bp repeat, suggesting that the 40 bp repeat is involved in the 
establishment of latency via regulation of the expression of ORF MK3 in a tissue 
specific/infection cycle specific fashion. For the first time, we have demonstrated the 
importance of an internal repeat in latency of a gamma herpesvirus and in the 
pathogenesis. Our data suggest that internal repeats could act as enhancer regions for 
certain virus specific genes, thus playing a role in affecting the phenotype of virus-
induced disease. 
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